#ariba_ref_name	ref_name	gene	var_only	flag	reads	cluster	ref_len	ref_base_assembled	pc_ident	ctg	ctg_len	ctg_cov	known_var	var_type	var_seq_type	known_var_change	has_known_var	ref_ctg_change	ref_ctg_effect	ref_start	ref_end	ref_nt	ctg_start	ctg_end	ctg_nt	smtls_total_depth	smtls_nts	smtls_nts_depth	var_description	free_text
CRP.3000518.AP009048.4153663_4154296.461	CRP.3000518.AP009048.4153663_4154296.461	1	0	539	344	CRP	633	633	99.53	CRP.l15.c17.ctg.1	1176	21.9	0	.	p	.	0	K29T	NONSYN	85	87	AAG	282	284	ACG	32;31;32	A;C;G	32;31;32	.	CRP is a global regulator that represses MdtEF multidrug efflux pump expression.;CRP
Enterobacter_aerogenes_omp36.3003385.AF335467.36_1164.2109	Enterobacter_aerogenes_omp36.3003385.AF335467.36_1164.2109	1	1	528	14	Enterobacter_aerogenes_omp36	1128	109	91.74	Enterobacter_aerogenes_omp36.l15.c4.ctg.1	112	3.4	0	.	p	.	0	Q321E	NONSYN	961	963	CAG	8	10	GAA	2;2;2	G;A;A	2;2;2	.	Enterobacter aerogenes omp36 mutants
Enterobacter_aerogenes_omp36.3003385.AF335467.36_1164.2109	Enterobacter_aerogenes_omp36.3003385.AF335467.36_1164.2109	1	1	528	14	Enterobacter_aerogenes_omp36	1128	109	91.74	Enterobacter_aerogenes_omp36.l15.c4.ctg.1	112	3.4	0	.	p	.	0	L329V	NONSYN	985	987	CTG	32	34	GTT	4;4;4	G;T;T	4;4;4	.	Enterobacter aerogenes omp36 mutants
Enterobacter_aerogenes_omp36.3003385.AF335467.36_1164.2109	Enterobacter_aerogenes_omp36.3003385.AF335467.36_1164.2109	1	1	528	14	Enterobacter_aerogenes_omp36	1128	109	91.74	Enterobacter_aerogenes_omp36.l15.c4.ctg.1	112	3.4	0	.	p	.	0	K354Q	NONSYN	1060	1062	AAG	107	109	CAG	2;1;1	C;A;G	2;1;1	.	Enterobacter aerogenes omp36 mutants
Escherichia_coli_EF_Tu.3003369.AE014075.3901532_3902762.3356	Escherichia_coli_EF_Tu.3003369.AE014075.3901532_3902762.3356	1	1	155	1212	Escherichia_coli_EF_Tu	1230	1230	99.84	Escherichia_coli_EF_Tu.l15.c30.ctg.1	1627	53.3	1	SNP	p	R234F	1	.	.	700	702	TTC	989	991	TTC	77;78;78	T;T;C	75;76;76	Escherichia_coli_EF_Tu.3003369.AE014075.3901532_3902762.3356:1:1:R234F:.:Sequence variants of Escherichia coli elongation factor Tu that confer resistance to Pulvomycin	Escherichia coli EF-Tu mutants conferring resistance to Pulvomycin
Escherichia_coli_EF_Tu.3003369.AE014075.3901532_3902762.3356	Escherichia_coli_EF_Tu.3003369.AE014075.3901532_3902762.3356	1	1	155	1212	Escherichia_coli_EF_Tu	1230	1230	99.84	Escherichia_coli_EF_Tu.l15.c30.ctg.1	1627	53.3	1	SNP	p	R334C	0	.	.	1000	1002	CGT	1289	1291	CGT	61;64;65	C;G;T	61;64;65	Escherichia_coli_EF_Tu.3003369.AE014075.3901532_3902762.3356:1:1:R334C:.:Sequence variants of Escherichia coli elongation factor Tu that confer resistance to Pulvomycin	Escherichia coli EF-Tu mutants conferring resistance to Pulvomycin
Escherichia_coli_EF_Tu.3003369.AE014075.3901532_3902762.3356	Escherichia_coli_EF_Tu.3003369.AE014075.3901532_3902762.3356	1	1	155	1212	Escherichia_coli_EF_Tu	1230	1230	99.84	Escherichia_coli_EF_Tu.l15.c30.ctg.1	1627	53.3	0	HET	.	.	.	T999C	.	999	999	T	1288	1288	T	59	T,C	31,28	.	Escherichia coli EF-Tu mutants conferring resistance to Pulvomycin
Escherichia_coli_EF_Tu.3003369.AE014075.3901532_3902762.3356	Escherichia_coli_EF_Tu.3003369.AE014075.3901532_3902762.3356	1	1	155	1212	Escherichia_coli_EF_Tu	1230	1230	99.84	Escherichia_coli_EF_Tu.l15.c30.ctg.1	1627	53.3	0	HET	.	.	.	C144T	.	144	144	C	433	433	C	58	C,T	36,22	.	Escherichia coli EF-Tu mutants conferring resistance to Pulvomycin
Escherichia_coli_EF_Tu.3003369.AE014075.3901532_3902762.3356	Escherichia_coli_EF_Tu.3003369.AE014075.3901532_3902762.3356	1	1	155	1212	Escherichia_coli_EF_Tu	1230	1230	99.84	Escherichia_coli_EF_Tu.l15.c30.ctg.1	1627	53.3	0	HET	.	.	.	C114T	.	114	114	C	403	403	C	59	C,T	38,21	.	Escherichia coli EF-Tu mutants conferring resistance to Pulvomycin
Escherichia_coli_EF_Tu.3003369.AE014075.3901532_3902762.3356	Escherichia_coli_EF_Tu.3003369.AE014075.3901532_3902762.3356	1	1	155	1212	Escherichia_coli_EF_Tu	1230	1230	99.84	Escherichia_coli_EF_Tu.l15.c30.ctg.1	1627	53.3	0	HET	.	.	.	T180C	.	180	180	T	469	469	T	64	T,C	37,25	.	Escherichia coli EF-Tu mutants conferring resistance to Pulvomycin
Escherichia_coli_EF_Tu.3003369.AE014075.3901532_3902762.3356	Escherichia_coli_EF_Tu.3003369.AE014075.3901532_3902762.3356	1	1	155	1212	Escherichia_coli_EF_Tu	1230	1230	99.84	Escherichia_coli_EF_Tu.l15.c30.ctg.1	1627	53.3	0	HET	.	.	.	T123A	.	123	123	T	412	412	T	62	T,A	41,21	.	Escherichia coli EF-Tu mutants conferring resistance to Pulvomycin
Escherichia_coli_EF_Tu.3003369.AE014075.3901532_3902762.3356	Escherichia_coli_EF_Tu.3003369.AE014075.3901532_3902762.3356	1	1	155	1212	Escherichia_coli_EF_Tu	1230	1230	99.84	Escherichia_coli_EF_Tu.l15.c30.ctg.1	1627	53.3	0	HET	.	.	.	T126G	.	126	126	T	415	415	T	63	T,G	41,21	.	Escherichia coli EF-Tu mutants conferring resistance to Pulvomycin
Escherichia_coli_EF_Tu.3003369.AE014075.3901532_3902762.3356	Escherichia_coli_EF_Tu.3003369.AE014075.3901532_3902762.3356	1	1	155	1212	Escherichia_coli_EF_Tu	1230	1230	99.84	Escherichia_coli_EF_Tu.l15.c30.ctg.1	1627	53.3	0	HET	.	.	.	C255T	.	255	255	C	544	544	C	69	C,T	38,31	.	Escherichia coli EF-Tu mutants conferring resistance to Pulvomycin
Escherichia_coli_mutant.3003889.HG738867.2233288_2234647.3666	Escherichia_coli_mutant.3003889.HG738867.2233288_2234647.3666	1	1	539	546	Escherichia_coli_mutant_1	1359	1359	99.85	Escherichia_coli_mutant_1.l15.c30.ctg.1	1805	22.7	1	SNP	p	E448K	1	E448K	NONSYN	1342	1344	GAA	1570	1572	AAA	18;18;17	A;A;A	18;18;17	Escherichia_coli_mutant.3003889.HG738867.2233288_2234647.3666:1:1:E448K:.:Mutations to the active importer GlpT, which is involved with the uptake of many phosphorylated sugars, confer resistance to fosfomycin by reducing import of the drug into the bacteria.	Escherichia coli mutant GlpT conferring resistance to fosfomycin
Escherichia_coli_mutant.3003890.HG738867.2934266_2935658.3667	Escherichia_coli_mutant.3003890.HG738867.2934266_2935658.3667	1	1	27	676	Escherichia_coli_mutant	1392	1392	99.43	Escherichia_coli_mutant.l15.c30.ctg.1	1847	27.3	1	SNP	p	E350Q	0	.	.	1048	1050	GAA	1343	1345	GAA	29;30;30	G;A;A	29;29;30	Escherichia_coli_mutant.3003890.HG738867.2934266_2935658.3667:1:1:E350Q:.:Mutations to the active importer UhpT, which is involved with the uptake of many phosphorylated sugars, confer resistance to fosfomycin by reducing import of the drug into the bacteria.	Escherichia coli mutant UhpT conferring resistance to fosfomycin
H_NS.3000676.NC_002695.1737553_1737967.218	H_NS.3000676.NC_002695.1737553_1737967.218	1	0	27	150	H_NS	414	414	99.03	H_NS.l6.c4.ctg.1	827	13.4	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	H-NS is a histone-like protein involved in global gene regulation in Gram-negative bacteria. It is a repressor of the membrane fusion protein genes acrE, mdtE, and emrK as well as nearby genes of many RND-type multidrug exporters.;H-NS
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	548	1720	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c30.ctg.3	518	120.0	0	.	n	.	0	A1136G	SNP	1136	1136	A	96	96	G	108	G	107	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	548	1720	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c30.ctg.3	518	120.0	0	.	n	.	0	T1138C	SNP	1138	1138	T	98	98	C	118	C	118	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	548	1720	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c30.ctg.3	518	120.0	0	.	n	.	0	T1142C	SNP	1142	1142	T	102	102	C	129	C	129	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	548	1720	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c30.ctg.3	518	120.0	0	.	n	.	0	C1170T	SNP	1170	1170	C	130	130	T	165	T	164	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	548	1720	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c30.ctg.3	518	120.0	0	.	n	.	0	T1220C	SNP	1220	1220	T	180	180	C	144	C	143	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	548	1720	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c30.ctg.3	518	120.0	0	.	n	.	0	T1245C	SNP	1245	1245	T	205	205	C	136	C	135	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	548	1720	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c30.ctg.3	518	120.0	0	.	n	.	0	G1253A	SNP	1253	1253	G	213	213	A	116	A	114	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	548	1720	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c30.ctg.3	518	120.0	0	.	n	.	0	G1256A	SNP	1256	1256	G	216	216	A	114	A	112	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	548	1720	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c30.ctg.3	518	120.0	0	.	n	.	0	C1258A	SNP	1258	1258	C	218	218	A	104	A	103	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	548	1720	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c30.ctg.3	518	120.0	0	.	n	.	0	G1266T	SNP	1266	1266	G	226	226	T	102	T	100	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	548	1720	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c30.ctg.3	518	120.0	0	.	n	.	0	T1267C	SNP	1267	1267	T	227	227	C	101	C	101	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	548	1720	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c30.ctg.3	518	120.0	0	.	n	.	0	T1275C	SNP	1275	1275	T	235	235	C	100	C	99	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	548	1720	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c30.ctg.3	518	120.0	0	.	n	.	0	G1276A	SNP	1276	1276	G	236	236	A	101	A	100	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	548	1720	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c30.ctg.3	518	120.0	0	.	n	.	0	A1281G	SNP	1281	1281	A	241	241	G	106	G	106	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	548	1720	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c30.ctg.3	518	120.0	0	.	n	.	0	T1283C	SNP	1283	1283	T	243	243	C	110	C	109	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	548	1720	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c30.ctg.3	518	120.0	0	.	n	.	0	G1288T	SNP	1288	1288	G	248	248	T	122	T	121	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	548	1720	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c30.ctg.3	518	120.0	0	.	n	.	0	A1296G	SNP	1296	1296	A	256	256	G	136	G	136	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	548	1720	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c30.ctg.3	518	120.0	0	.	n	.	0	T1299G	SNP	1299	1299	T	259	259	G	134	G	134	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	548	1720	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c30.ctg.3	518	120.0	0	.	n	.	0	A1300T	SNP	1300	1300	A	260	260	T	133	T	132	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	548	1720	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c30.ctg.3	518	120.0	0	.	n	.	0	C1356T	SNP	1356	1356	C	316	316	T	163	T	163	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	548	1720	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c30.ctg.3	518	120.0	0	.	n	.	0	A1358G	SNP	1358	1358	A	318	318	G	160	G	160	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	548	1720	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c30.ctg.3	518	120.0	0	.	n	.	0	T1368C	SNP	1368	1368	T	328	328	C	147	C	147	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	548	1720	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c30.ctg.3	518	120.0	0	.	n	.	0	G1370A	SNP	1370	1370	G	330	330	A	143	A	143	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	548	1720	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c30.ctg.3	518	120.0	0	.	n	.	0	C1406.	DEL	1406	1406	C	365	365	C	92	C	92	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	548	1720	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c30.ctg.3	518	120.0	0	.	n	.	0	.1409C	INS	1409	1409	T	369	369	C	88	C	88	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	548	1720	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c30.ctg.3	518	120.0	0	.	n	.	0	C1431A	SNP	1431	1431	C	391	391	A	59	A	59	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	548	1720	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c30.ctg.3	518	120.0	0	.	n	.	0	C1432A	SNP	1432	1432	C	392	392	A	59	A	59	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	548	1720	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c30.ctg.3	518	120.0	0	.	n	.	0	A1441G	SNP	1441	1441	A	401	401	G	62	G	61	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	548	1720	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c30.ctg.3	518	120.0	0	.	n	.	0	T1464C	SNP	1464	1464	T	424	424	C	62	C	62	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	548	1720	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c30.ctg.3	518	120.0	0	.	n	.	0	G1473T	SNP	1473	1473	G	433	433	T	72	T	72	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	548	1720	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c30.ctg.3	518	120.0	0	.	n	.	0	A1475G	SNP	1475	1475	A	435	435	G	71	G	71	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	548	1720	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c30.ctg.3	518	120.0	0	.	n	.	0	A1548T	SNP	1548	1548	A	508	508	T	55	T	55	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	548	1720	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c30.ctg.3	518	120.0	1	SNP	n	C1194G	0	.	.	1194	1194	C	154	154	C	177	C	176	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252:0:0:C1194G:.:Point mutations in the helix 34 region of 16S rRNA of Pasteurella multocida can confer resistance to spectinomycin	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	548	1720	Pasteurella_multocida_16S	1551	184	92.93	Pasteurella_multocida_16S.l15.c30.ctg.5	184	46.0	0	.	n	.	0	C990G	SNP	990	990	C	59	59	G	38	G	30	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	548	1720	Pasteurella_multocida_16S	1551	184	92.93	Pasteurella_multocida_16S.l15.c30.ctg.5	184	46.0	0	.	n	.	0	T1002A	SNP	1002	1002	T	71	71	A	31	A	31	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	548	1720	Pasteurella_multocida_16S	1551	184	92.93	Pasteurella_multocida_16S.l15.c30.ctg.5	184	46.0	0	.	n	.	0	A1004G	SNP	1004	1004	A	73	73	G	32	G	32	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	548	1720	Pasteurella_multocida_16S	1551	184	92.93	Pasteurella_multocida_16S.l15.c30.ctg.5	184	46.0	0	.	n	.	0	C1011T	SNP	1011	1011	C	80	80	T	30	T	30	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	548	1720	Pasteurella_multocida_16S	1551	184	92.93	Pasteurella_multocida_16S.l15.c30.ctg.5	184	46.0	0	.	n	.	0	C1023A	SNP	1023	1023	C	92	92	A	39	A	38	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	548	1720	Pasteurella_multocida_16S	1551	184	92.93	Pasteurella_multocida_16S.l15.c30.ctg.5	184	46.0	0	.	n	.	0	T1024A	SNP	1024	1024	T	93	93	A	39	A	38	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	548	1720	Pasteurella_multocida_16S	1551	184	92.93	Pasteurella_multocida_16S.l15.c30.ctg.5	184	46.0	0	.	n	.	0	T1041G	SNP	1041	1041	T	110	110	G	40	G	40	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	548	1720	Pasteurella_multocida_16S	1551	184	92.93	Pasteurella_multocida_16S.l15.c30.ctg.5	184	46.0	0	.	n	.	0	A1042T	SNP	1042	1042	A	111	111	T	40	T	40	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	548	1720	Pasteurella_multocida_16S	1551	175	92.05	Pasteurella_multocida_16S.l15.c30.ctg.6	175	20.3	0	.	n	.	0	C990G	SNP	990	990	C	50	50	G	27	G	26	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	548	1720	Pasteurella_multocida_16S	1551	175	92.05	Pasteurella_multocida_16S.l15.c30.ctg.6	175	20.3	0	.	n	.	0	T1002A	SNP	1002	1002	T	62	62	A	27	A	27	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	548	1720	Pasteurella_multocida_16S	1551	175	92.05	Pasteurella_multocida_16S.l15.c30.ctg.6	175	20.3	0	.	n	.	0	A1003C	SNP	1003	1003	A	63	63	C	27	C	27	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	548	1720	Pasteurella_multocida_16S	1551	175	92.05	Pasteurella_multocida_16S.l15.c30.ctg.6	175	20.3	0	.	n	.	0	G1008C	SNP	1008	1008	G	68	68	C	27	C	27	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	548	1720	Pasteurella_multocida_16S	1551	175	92.05	Pasteurella_multocida_16S.l15.c30.ctg.6	175	20.3	0	.	n	.	0	C1011T	SNP	1011	1011	C	71	71	T	27	T	27	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	548	1720	Pasteurella_multocida_16S	1551	175	92.05	Pasteurella_multocida_16S.l15.c30.ctg.6	175	20.3	0	.	n	.	0	T1012C	SNP	1012	1012	T	72	72	C	27	C	27	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	548	1720	Pasteurella_multocida_16S	1551	175	92.05	Pasteurella_multocida_16S.l15.c30.ctg.6	175	20.3	0	.	n	.	0	C1023A	SNP	1023	1023	C	82	82	A	28	A	28	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	548	1720	Pasteurella_multocida_16S	1551	175	92.05	Pasteurella_multocida_16S.l15.c30.ctg.6	175	20.3	0	.	n	.	0	.1025G	INS	1025	1025	T	85	85	G	28	G	28	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	548	1720	Pasteurella_multocida_16S	1551	175	92.05	Pasteurella_multocida_16S.l15.c30.ctg.6	175	20.3	0	.	n	.	0	T1041G	SNP	1041	1041	T	101	101	G	25	G	25	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	548	1720	Pasteurella_multocida_16S	1551	175	92.05	Pasteurella_multocida_16S.l15.c30.ctg.6	175	20.3	0	.	n	.	0	A1042T	SNP	1042	1042	A	102	102	T	25	T	24	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
PmrB.3003583.NC_007779.4336858_4337950.2119	PmrB.3003583.NC_007779.4336858_4337950.2119	1	0	539	474	PmrB_1	1092	1092	99.08	PmrB_1.l15.c30.ctg.1	1558	22.7	0	.	p	.	0	H2R	NONSYN	4	6	CAT	249	251	CGT	27;26;28	C;G;T	27;26;28	.	Histidine protein kinase sensor Lipid A modification gene; part of a two-component system involved in polymyxin resistance that senses high extracellular Fe(2+);PmrB
PmrB.3003583.NC_007779.4336858_4337950.2119	PmrB.3003583.NC_007779.4336858_4337950.2119	1	0	539	474	PmrB_1	1092	1092	99.08	PmrB_1.l15.c30.ctg.1	1558	22.7	0	.	p	.	0	V30I	NONSYN	88	90	GTC	333	335	ATC	26;25;25	A;T;C	25;25;24	.	Histidine protein kinase sensor Lipid A modification gene; part of a two-component system involved in polymyxin resistance that senses high extracellular Fe(2+);PmrB
PmrB.3003583.NC_007779.4336858_4337950.2119	PmrB.3003583.NC_007779.4336858_4337950.2119	1	0	539	474	PmrB_1	1092	1092	99.08	PmrB_1.l15.c30.ctg.1	1558	22.7	0	.	p	.	0	D283G	NONSYN	847	849	GAC	1092	1094	GGC	22;22;22	G;G;C	22;22;22	.	Histidine protein kinase sensor Lipid A modification gene; part of a two-component system involved in polymyxin resistance that senses high extracellular Fe(2+);PmrB
PmrC.3003576.AP009048.4338624_4340268.2117	PmrC.3003576.AP009048.4338624_4340268.2117	1	0	539	752	PmrC	1644	1644	99.15	PmrC.l15.c4.ctg.1	2274	24.9	0	.	p	.	0	R8S	NONSYN	22	24	AGA	293	295	AGC	10;10;10	A;G;C	10;10;10	.	PmrC;PmrC mediates the modification of Lipid A by the addition of 4-amino-4-deoxy-L-arabinose (L-Ara4N) and phosphoethanolamine, resulting in a less negative cell membrane and decreased binding of polymyxin B.
PmrC.3003576.AP009048.4338624_4340268.2117	PmrC.3003576.AP009048.4338624_4340268.2117	1	0	539	752	PmrC	1644	1644	99.15	PmrC.l15.c4.ctg.1	2274	24.9	0	.	p	.	0	I142L	NONSYN	424	426	ATA	695	697	CTA	22;21;21	C;T;A	21;21;21	.	PmrC;PmrC mediates the modification of Lipid A by the addition of 4-amino-4-deoxy-L-arabinose (L-Ara4N) and phosphoethanolamine, resulting in a less negative cell membrane and decreased binding of polymyxin B.
PmrC.3003576.AP009048.4338624_4340268.2117	PmrC.3003576.AP009048.4338624_4340268.2117	1	0	539	752	PmrC	1644	1644	99.15	PmrC.l15.c4.ctg.1	2274	24.9	0	.	p	.	0	R315Q	NONSYN	943	945	CGA	1214	1216	CAA	36;36;35	C;A;A	35;35;34	.	PmrC;PmrC mediates the modification of Lipid A by the addition of 4-amino-4-deoxy-L-arabinose (L-Ara4N) and phosphoethanolamine, resulting in a less negative cell membrane and decreased binding of polymyxin B.
PmrC.3003576.AP009048.4338624_4340268.2117	PmrC.3003576.AP009048.4338624_4340268.2117	1	0	539	752	PmrC	1644	1644	99.15	PmrC.l15.c4.ctg.1	2274	24.9	0	.	p	.	0	D348G	NONSYN	1042	1044	GAT	1313	1315	GGT	44;40;40	G;G;T	44;40;39	.	PmrC;PmrC mediates the modification of Lipid A by the addition of 4-amino-4-deoxy-L-arabinose (L-Ara4N) and phosphoethanolamine, resulting in a less negative cell membrane and decreased binding of polymyxin B.
PmrC.3003576.AP009048.4338624_4340268.2117	PmrC.3003576.AP009048.4338624_4340268.2117	1	0	539	752	PmrC	1644	1644	99.15	PmrC.l15.c4.ctg.1	2274	24.9	0	.	p	.	0	I538V	NONSYN	1612	1614	ATT	1883	1885	GTT	24;24;24	G;T;T	24;24;24	.	PmrC;PmrC mediates the modification of Lipid A by the addition of 4-amino-4-deoxy-L-arabinose (L-Ara4N) and phosphoethanolamine, resulting in a less negative cell membrane and decreased binding of polymyxin B.
PmrE.3003577.U00096.2098446_2099613.2116	PmrE.3003577.U00096.2098446_2099613.2116	1	0	539	268	PmrE	1167	1167	96.83	PmrE.l15.c30.ctg.1	1637	12.4	0	.	p	.	0	A125E	NONSYN	373	375	GCA	579	581	GAA	15;15;15	G;A;A	15;15;15	.	PmrE is required for the synthesis and transfer of 4-amino-4-deoxy-L-arabinose (Ara4N) to Lipid A, which allows gram-negative bacteria to resist the antimicrobial activity of cationic antimicrobial peptides and antibiotics such as polymyxin;PmrE
PmrE.3003577.U00096.2098446_2099613.2116	PmrE.3003577.U00096.2098446_2099613.2116	1	0	539	268	PmrE	1167	1167	96.83	PmrE.l15.c30.ctg.1	1637	12.4	0	.	p	.	0	M185T	NONSYN	553	555	ATG	759	761	ACC	12;11;11	A;C;C	12;11;11	.	PmrE is required for the synthesis and transfer of 4-amino-4-deoxy-L-arabinose (Ara4N) to Lipid A, which allows gram-negative bacteria to resist the antimicrobial activity of cationic antimicrobial peptides and antibiotics such as polymyxin;PmrE
PmrE.3003577.U00096.2098446_2099613.2116	PmrE.3003577.U00096.2098446_2099613.2116	1	0	539	268	PmrE	1167	1167	96.83	PmrE.l15.c30.ctg.1	1637	12.4	0	.	p	.	0	S225T	NONSYN	673	675	TCC	879	881	ACT	16;16;16	A;C;T	16;16;16	.	PmrE is required for the synthesis and transfer of 4-amino-4-deoxy-L-arabinose (Ara4N) to Lipid A, which allows gram-negative bacteria to resist the antimicrobial activity of cationic antimicrobial peptides and antibiotics such as polymyxin;PmrE
PmrE.3003577.U00096.2098446_2099613.2116	PmrE.3003577.U00096.2098446_2099613.2116	1	0	539	268	PmrE	1167	1167	96.83	PmrE.l15.c30.ctg.1	1637	12.4	0	.	p	.	0	T355I	NONSYN	1063	1065	ACC	1269	1271	ATC	12;12;12	A;T;C	12;12;12	.	PmrE is required for the synthesis and transfer of 4-amino-4-deoxy-L-arabinose (Ara4N) to Lipid A, which allows gram-negative bacteria to resist the antimicrobial activity of cationic antimicrobial peptides and antibiotics such as polymyxin;PmrE
PmrF.3003578.U00096.2367070_2368039.2115	PmrF.3003578.U00096.2367070_2368039.2115	1	0	27	400	PmrF	969	969	99.38	PmrF.l15.c4.ctg.1	1528	19.7	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	PmrF;PmrF is required for the synthesis and transfer of 4-amino-4-deoxy-L-arabinose (Ara4N) to Lipid A, which allows gram-negative bacteria to resist the antimicrobial activity of cationic antimicrobial peptides and antibiotics such as polymyxin
TEM_183.3001045.HQ529916.110_971.1647	TEM_183.3001045.HQ529916.110_971.1647	1	0	539	2248	TEM_1+	861	861	99.88	TEM_1+.l15.c30.ctg.1	1472	113.2	0	.	p	.	0	L228F	NONSYN	682	684	CTT	1021	1023	TTT	158;159;162	T;T;T	153;159;162	.	TEM-183 is a broad-spectrum beta-lactamase.;TEM-183
acrB.3000216.DQ679966.1515_4662.624	acrB.3000216.DQ679966.1515_4662.624	1	0	528	32	acrB	3147	203	90.64	acrB.l6.c30.ctg.1	205	2.9	0	.	p	.	0	N146D	NONSYN	436	438	AAC	166	168	GAT	5;5;5	G;A;T	5;5;5	.	acrB;Protein subunit of AcrA-AcrB-TolC multidrug efflux complex. AcrB functions as a herterotrimer which forms the inner membrane component and is primarily responsible for substrate recognition and energy transduction by acting as a drug/proton antiporter.
acrD.3000491.NC_007779.2586250_2589364.664	acrD.3000491.NC_007779.2586250_2589364.664	1	0	531	1156	acrD	3114	3114	99.07	acrD.l15.c30.ctg.1	3561	24.4	0	.	p	.	0	T85I	NONSYN	253	255	ACC	472	474	ATC	25;25;26	A;T;C	25;25;26	.	AcrD is an aminoglycoside efflux pump expressed in E. coli. Its expression can be induced by indole, and is regulated by baeRS and cpxAR.;acrD
acrD.3000491.NC_007779.2586250_2589364.664	acrD.3000491.NC_007779.2586250_2589364.664	1	0	531	1156	acrD	3114	3114	99.07	acrD.l15.c30.ctg.1	3561	24.4	0	.	p	.	0	Q656K	NONSYN	1966	1968	CAA	2185	2187	AAG	23;23;22	A;A;G	23;23;22	.	AcrD is an aminoglycoside efflux pump expressed in E. coli. Its expression can be induced by indole, and is regulated by baeRS and cpxAR.;acrD
acrD.3000491.NC_007779.2586250_2589364.664	acrD.3000491.NC_007779.2586250_2589364.664	1	0	531	1156	acrD	3114	3114	99.07	acrD.l15.c30.ctg.1	3561	24.4	0	.	p	.	0	S811trunc	TRUNC	2431	2431	T	2650	2650	T	31	T	31	.	AcrD is an aminoglycoside efflux pump expressed in E. coli. Its expression can be induced by indole, and is regulated by baeRS and cpxAR.;acrD
acrE.3000499.U00096.3413863_3415021.333	acrE.3000499.U00096.3413863_3415021.333	1	0	539	476	acrE	1158	1158	98.79	acrE.l15.c30.ctg.1	1605	22.3	0	.	p	.	0	A22V	NONSYN	64	66	GCC	225	227	GTC	13;13;13	G;T;C	13;13;13	.	AcrE is a membrane fusion protein, similar to AcrA.;acrE
acrE.3000499.U00096.3413863_3415021.333	acrE.3000499.U00096.3413863_3415021.333	1	0	539	476	acrE	1158	1158	98.79	acrE.l15.c30.ctg.1	1605	22.3	0	.	p	.	0	S269C	NONSYN	805	807	AGC	966	968	TGC	30;30;31	T;G;C	30;30;31	.	AcrE is a membrane fusion protein, similar to AcrA.;acrE
acrF.3000502.U00096.3415032_3418137.700	acrF.3000502.U00096.3415032_3418137.700	1	0	531	1322	acrF	3105	3105	98.71	acrF.l15.c4.ctg.1	3586	27.8	0	.	p	.	0	S46trunc	TRUNC	136	136	T	388	388	T	20	T	19	.	AcrF is a inner membrane transporter, similar to AcrB.;acrF
acrF.3000502.U00096.3415032_3418137.700	acrF.3000502.U00096.3415032_3418137.700	1	0	531	1322	acrF	3105	3105	98.71	acrF.l15.c4.ctg.1	3586	27.8	0	.	p	.	0	G148D	NONSYN	442	444	GGC	694	696	GAC	25;25;25	G;A;C	24;25;25	.	AcrF is a inner membrane transporter, similar to AcrB.;acrF
acrF.3000502.U00096.3415032_3418137.700	acrF.3000502.U00096.3415032_3418137.700	1	0	531	1322	acrF	3105	3105	98.71	acrF.l15.c4.ctg.1	3586	27.8	0	.	p	.	0	F240L	NONSYN	718	720	TTT	970	972	TTA	20;20;22	T;T;A	20;20;22	.	AcrF is a inner membrane transporter, similar to AcrB.;acrF
acrF.3000502.U00096.3415032_3418137.700	acrF.3000502.U00096.3415032_3418137.700	1	0	531	1322	acrF	3105	3105	98.71	acrF.l15.c4.ctg.1	3586	27.8	0	.	p	.	0	D301N	NONSYN	901	903	GAT	1153	1155	AAT	22;23;23	A;A;T	22;23;23	.	AcrF is a inner membrane transporter, similar to AcrB.;acrF
acrF.3000502.U00096.3415032_3418137.700	acrF.3000502.U00096.3415032_3418137.700	1	0	531	1322	acrF	3105	3105	98.71	acrF.l15.c4.ctg.1	3586	27.8	0	.	p	.	0	K599N	NONSYN	1795	1797	AAG	2047	2049	AAT	32;32;32	A;A;T	32;32;32	.	AcrF is a inner membrane transporter, similar to AcrB.;acrF
acrF.3000502.U00096.3415032_3418137.700	acrF.3000502.U00096.3415032_3418137.700	1	0	531	1322	acrF	3105	3105	98.71	acrF.l15.c4.ctg.1	3586	27.8	0	.	p	.	0	N637S	NONSYN	1909	1911	AAT	2161	2163	AGT	23;24;23	A;G;T	23;24;22	.	AcrF is a inner membrane transporter, similar to AcrB.;acrF
acrF.3000502.U00096.3415032_3418137.700	acrF.3000502.U00096.3415032_3418137.700	1	0	531	1322	acrF	3105	3105	98.71	acrF.l15.c4.ctg.1	3586	27.8	0	.	p	.	0	L770V	NONSYN	2308	2310	TTG	2560	2562	GTG	29;29;29	G;T;G	29;29;29	.	AcrF is a inner membrane transporter, similar to AcrB.;acrF
acrF.3000502.U00096.3415032_3418137.700	acrF.3000502.U00096.3415032_3418137.700	1	0	531	1322	acrF	3105	3105	98.71	acrF.l15.c4.ctg.1	3586	27.8	0	.	p	.	0	E955K	NONSYN	2863	2865	GAG	3115	3117	AAG	27;27;27	A;A;G	27;27;27	.	AcrF is a inner membrane transporter, similar to AcrB.;acrF
acrR.3003807.NC_000913.3.485760_486408.3575	acrR.3003807.NC_000913.3.485760_486408.3575	1	1	27	248	acrR_2	648	648	99.54	acrR_2.l15.c30.ctg.1	1201	15.4	1	SNP	p	R45C	0	.	.	133	135	CGC	381	383	CGC	33;31;31	C;G;C	33;31;30	acrR.3003807.NC_000913.3.485760_486408.3575:1:1:R45C:.:AcrR is a repressor of the AcrAB-TolC multidrug efflux complex. AcrR mutations result in high level antibiotic resistance. The mutations associated with this model are specific to E. coli.	Escherichia coli acrR mutants resulting in antibiotic resistance
acrS.3000656.U00096.3412802_3413465.551	acrS.3000656.U00096.3412802_3413465.551	1	0	539	252	acrS	663	663	98.64	acrS.l15.c30.ctg.1	1079	17.6	0	.	p	.	0	L34F	NONSYN	100	102	CTC	281	283	TTC	23;23;23	T;T;C	23;23;23	.	acrS;AcrS is a repressor of the AcrAB efflux complex and is associated with the expression of AcrEF. AcrS is believed to regulate a switch between AcrAB and AcrEF efflux.
acrS.3000656.U00096.3412802_3413465.551	acrS.3000656.U00096.3412802_3413465.551	1	0	539	252	acrS	663	663	98.64	acrS.l15.c30.ctg.1	1079	17.6	0	.	p	.	0	E122G	NONSYN	364	366	GAG	545	547	GGG	32;33;33	G;G;G	31;33;33	.	acrS;AcrS is a repressor of the AcrAB efflux complex and is associated with the expression of AcrEF. AcrS is believed to regulate a switch between AcrAB and AcrEF efflux.
adiY.3003828.NC_000913.3.4337167_4337929.3591	adiY.3003828.NC_000913.3.4337167_4337929.3591	1	0	539	246	adiY	762	762	99.61	adiY.l15.c17.ctg.1	1149	15.6	0	.	p	.	0	V136L	NONSYN	406	408	GTT	530	532	CTT	21;19;19	C;T;T	21;19;19	.	adiY is a DNA-binding transcriptional activator of the adi system. Implicated in arginine-dependent acid resistance in Escherichia coli.;adiY
alaS.3003830.NC_000913.3.2819380_2822011.3592	alaS.3003830.NC_000913.3.2819380_2822011.3592	1	0	539	1246	alaS	2631	2631	98.9	alaS.l15.c30.ctg.1	3308	28.3	0	.	p	.	0	T618A	NONSYN	1852	1854	ACA	2181	2183	GCA	37;37;35	G;C;A	37;37;35	.	alanyl-tRNA synthetase conferring resistance to novobiocin in Escherichia coli;aminocoumarin resistant alaS
alaS.3003830.NC_000913.3.2819380_2822011.3592	alaS.3003830.NC_000913.3.2819380_2822011.3592	1	0	539	1246	alaS	2631	2631	98.9	alaS.l15.c30.ctg.1	3308	28.3	0	.	p	.	0	A705T	NONSYN	2113	2115	GCC	2442	2444	ACC	38;38;39	A;C;C	36;37;39	.	alanyl-tRNA synthetase conferring resistance to novobiocin in Escherichia coli;aminocoumarin resistant alaS
alaS.3003830.NC_000913.3.2819380_2822011.3592	alaS.3003830.NC_000913.3.2819380_2822011.3592	1	0	539	1246	alaS	2631	2631	98.9	alaS.l15.c30.ctg.1	3308	28.3	0	.	p	.	0	V808A	NONSYN	2422	2424	GTC	2751	2753	GCC	43;42;41	G;C;C	43;42;41	.	alanyl-tRNA synthetase conferring resistance to novobiocin in Escherichia coli;aminocoumarin resistant alaS
arnA.3002985.U00096.2368038_2370021.355	arnA.3002985.U00096.2368038_2370021.355	1	0	539	680	arnA_1	1983	1983	98.24	arnA_1.l15.c30.ctg.1	2427	21.0	0	.	p	.	0	G37A	NONSYN	109	111	GGT	295	297	GCT	11;11;10	G;C;T	11;11;10	.	arnA;arnA modifies lipid A with 4-amino-4-deoxy-L-arabinose (Ara4N) which allows gram-negative bacteria to resist the antimicrobial activity of cationic antimicrobial peptides and antibiotics such as polymyxin. arnA is found in E. coli and P. aeruginosa.
arnA.3002985.U00096.2368038_2370021.355	arnA.3002985.U00096.2368038_2370021.355	1	0	539	680	arnA_1	1983	1983	98.24	arnA_1.l15.c30.ctg.1	2427	21.0	0	.	p	.	0	D77E	NONSYN	229	231	GAT	415	417	GAG	23;22;22	G;A;G	23;22;22	.	arnA;arnA modifies lipid A with 4-amino-4-deoxy-L-arabinose (Ara4N) which allows gram-negative bacteria to resist the antimicrobial activity of cationic antimicrobial peptides and antibiotics such as polymyxin. arnA is found in E. coli and P. aeruginosa.
arnA.3002985.U00096.2368038_2370021.355	arnA.3002985.U00096.2368038_2370021.355	1	0	539	680	arnA_1	1983	1983	98.24	arnA_1.l15.c30.ctg.1	2427	21.0	0	.	p	.	0	Y89C	NONSYN	265	267	TAC	451	453	TGC	16;17;18	T;G;C	16;17;18	.	arnA;arnA modifies lipid A with 4-amino-4-deoxy-L-arabinose (Ara4N) which allows gram-negative bacteria to resist the antimicrobial activity of cationic antimicrobial peptides and antibiotics such as polymyxin. arnA is found in E. coli and P. aeruginosa.
arnA.3002985.U00096.2368038_2370021.355	arnA.3002985.U00096.2368038_2370021.355	1	0	539	680	arnA_1	1983	1983	98.24	arnA_1.l15.c30.ctg.1	2427	21.0	0	.	p	.	0	I150V	NONSYN	448	450	ATT	634	636	GTT	25;25;25	G;T;T	25;25;25	.	arnA;arnA modifies lipid A with 4-amino-4-deoxy-L-arabinose (Ara4N) which allows gram-negative bacteria to resist the antimicrobial activity of cationic antimicrobial peptides and antibiotics such as polymyxin. arnA is found in E. coli and P. aeruginosa.
arnA.3002985.U00096.2368038_2370021.355	arnA.3002985.U00096.2368038_2370021.355	1	0	539	680	arnA_1	1983	1983	98.24	arnA_1.l15.c30.ctg.1	2427	21.0	0	.	p	.	0	R200H	NONSYN	598	600	CGC	784	786	CAC	29;29;29	C;A;C,T	29;29;28,1	.	arnA;arnA modifies lipid A with 4-amino-4-deoxy-L-arabinose (Ara4N) which allows gram-negative bacteria to resist the antimicrobial activity of cationic antimicrobial peptides and antibiotics such as polymyxin. arnA is found in E. coli and P. aeruginosa.
arnA.3002985.U00096.2368038_2370021.355	arnA.3002985.U00096.2368038_2370021.355	1	0	539	680	arnA_1	1983	1983	98.24	arnA_1.l15.c30.ctg.1	2427	21.0	0	.	p	.	0	T295M	NONSYN	883	885	ACG	1069	1071	ATG	32;32;30	A;T;G	31;31;29	.	arnA;arnA modifies lipid A with 4-amino-4-deoxy-L-arabinose (Ara4N) which allows gram-negative bacteria to resist the antimicrobial activity of cationic antimicrobial peptides and antibiotics such as polymyxin. arnA is found in E. coli and P. aeruginosa.
arnA.3002985.U00096.2368038_2370021.355	arnA.3002985.U00096.2368038_2370021.355	1	0	539	680	arnA_1	1983	1983	98.24	arnA_1.l15.c30.ctg.1	2427	21.0	0	.	p	.	0	H627R	NONSYN	1879	1881	CAC	2065	2067	CGC	21;20;20	C;G;C	21;20;20	.	arnA;arnA modifies lipid A with 4-amino-4-deoxy-L-arabinose (Ara4N) which allows gram-negative bacteria to resist the antimicrobial activity of cationic antimicrobial peptides and antibiotics such as polymyxin. arnA is found in E. coli and P. aeruginosa.
arnA.3002985.U00096.2368038_2370021.355	arnA.3002985.U00096.2368038_2370021.355	1	0	539	680	arnA_1	1983	1983	98.24	arnA_1.l15.c30.ctg.1	2427	21.0	0	.	p	.	0	L646Q	NONSYN	1936	1938	CTG	2122	2124	CAG	20;21;22	C;A;G	20;21;22	.	arnA;arnA modifies lipid A with 4-amino-4-deoxy-L-arabinose (Ara4N) which allows gram-negative bacteria to resist the antimicrobial activity of cationic antimicrobial peptides and antibiotics such as polymyxin. arnA is found in E. coli and P. aeruginosa.
bacA.3002986.U00096.3203309_3204131.36	bacA.3002986.U00096.3203309_3204131.36	1	0	539	296	bacA	822	822	98.54	bacA.l15.c4.ctg.1	1206	18.1	0	.	p	.	0	S221T	NONSYN	661	663	AGC	977	979	ACC	13;13;13	A;C;C	13;13;13	.	bacA is a gene that recycles undecaprenyl pyrophosphate during cell wall biosynthesis which confers resistance to bacitracin;bacA
bacA.3002986.U00096.3203309_3204131.36	bacA.3002986.U00096.3203309_3204131.36	1	0	539	296	bacA	822	822	98.54	bacA.l15.c4.ctg.1	1206	18.1	0	.	p	.	0	P225S	NONSYN	673	675	CCG	989	991	TCG	14;14;14	T;C;G	14;14;13	.	bacA is a gene that recycles undecaprenyl pyrophosphate during cell wall biosynthesis which confers resistance to bacitracin;bacA
baeR.3000828.NC_007779.2166412_2167135.676	baeR.3000828.NC_007779.2166412_2167135.676	1	0	27	288	baeR	723	723	97.79	baeR.l15.c30.ctg.1	1175	18.0	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	BaeR is a response regulator that promotes the expression of MdtABC and AcrD efflux complexes.;baeR
baeS.3000829.AP009048.2165012_2166416.608	baeS.3000829.AP009048.2165012_2166416.608	1	0	539	468	baeS	1404	1404	98.86	baeS.l15.c4.ctg.1	1921	18.3	0	.	p	.	0	Q376K	NONSYN	1126	1128	CAA	1395	1397	AAA	19;19;21	A;A;A	19;19;21	.	BaeS is a sensor kinase in the BaeSR regulatory system. While it phosphorylates BaeR to increase its activity, BaeS is not necessary for overexpressed BaeR to confer resistance.;baeS
baeS.3000829.AP009048.2165012_2166416.608	baeS.3000829.AP009048.2165012_2166416.608	1	0	539	468	baeS	1404	1404	98.86	baeS.l15.c4.ctg.1	1921	18.3	0	.	p	.	0	G380E	NONSYN	1138	1140	GGG	1407	1409	GAG	19;19;19	G;A;G	19;19;19	.	BaeS is a sensor kinase in the BaeSR regulatory system. While it phosphorylates BaeR to increase its activity, BaeS is not necessary for overexpressed BaeR to confer resistance.;baeS
baeS.3000829.AP009048.2165012_2166416.608	baeS.3000829.AP009048.2165012_2166416.608	1	0	539	468	baeS	1404	1404	98.86	baeS.l15.c4.ctg.1	1921	18.3	0	.	p	.	0	R382H	NONSYN	1144	1146	CGC	1413	1415	CAC	19;19;19	C;A;C,A	19;19;18,1	.	BaeS is a sensor kinase in the BaeSR regulatory system. While it phosphorylates BaeR to increase its activity, BaeS is not necessary for overexpressed BaeR to confer resistance.;baeS
baeS.3000829.AP009048.2165012_2166416.608	baeS.3000829.AP009048.2165012_2166416.608	1	0	539	468	baeS	1404	1404	98.86	baeS.l15.c4.ctg.1	1921	18.3	0	.	p	.	0	D400E	NONSYN	1198	1200	GAT	1467	1469	GAG	15;15;15	G;A,C;G	15;13,1;15	.	BaeS is a sensor kinase in the BaeSR regulatory system. While it phosphorylates BaeR to increase its activity, BaeS is not necessary for overexpressed BaeR to confer resistance.;baeS
cpxA.3000830.NC_002695.4903561_4904935.605	cpxA.3000830.NC_002695.4903561_4904935.605	1	0	27	610	cpxA	1374	1374	98.91	cpxA.l15.c4.ctg.1	2034	22.6	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	cpxA;CpxA is a membrane-localized sensor kinase that is activated by envelope stress. It starts a kinase cascade that activates CpxR, which promotes efflux complex expression.
cpxR.3000831.NC_002695.4904931_4905630.142	cpxR.3000831.NC_002695.4904931_4905630.142	1	0	27	350	cpxR	699	699	99.43	cpxR.l15.c4.ctg.1	1215	21.6	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	cpxR;CpxR is a regulator that promotes acrD expression when phosphorylated by a cascade involving CpxA, a sensor kinase.
cysB.3003840.NC_000913.3.1333854_1334829.3604	cysB.3003840.NC_000913.3.1333854_1334829.3604	1	0	539	356	cysB	975	975	99.28	cysB.l15.c4.ctg.1	1335	20.1	0	.	p	.	0	A146T	NONSYN	436	438	GCT	635	637	ACT	25;24;24	A;C;T,A	25;24;23,1	.	Positive regulator of gene expression in the cysteine regulon. cysB mutants confer resistance to novobiocin, an aminocoumarin antibiotic, in Escherichia coli.;aminocoumarin resistant cysB
emrA.3000027.AP009048.2810082_2811255.411	emrA.3000027.AP009048.2810082_2811255.411	1	0	539	446	emrA	1173	1173	98.29	emrA.l6.c30.ctg.1	1538	21.5	0	.	p	.	0	I219V	NONSYN	655	657	ATC	854	856	GTC	25;25;26	G;T;C	25;25;26	.	emrA;EmrA is a membrane fusion protein, providing an efflux pathway with EmrB and TolC between the inner and outer membranes of E. coli, a Gram-negative bacterium.
emrB.3000074.U00096.2812615_2814154.20	emrB.3000074.U00096.2812615_2814154.20	1	0	539	720	emrB	1539	1539	99.74	emrB.l15.c4.ctg.1	2156	25.1	0	.	p	.	0	E197K	NONSYN	589	591	GAA	892	894	AAA	39;39;38	A;A;A	39;39;38	.	emrB is a translocase in the emrB -TolC efflux protein in E. coli. It recognizes substrates including carbonyl cyanide m-chlorophenylhydrazone (CCCP), nalidixic acid, and thioloactomycin.;emrB
emrD.3000309.GG749185.1.116812_118003.3622	emrD.3000309.GG749185.1.116812_118003.3622	1	0	539	560	emrD	1191	1191	98.4	emrD.l15.c4.ctg.1	1786	23.7	0	.	p	.	0	G209S	NONSYN	625	627	GGC	859	861	AGC	35;35;36	A;G;C	35;35;36	.	emrD;EmrD is a multidrug transporter from the Major Facilitator Superfamily (MFS) primarily found in Escherichia coli. EmrD couples efflux of amphipathic compounds with proton import across the plasma membrane.
emrE.3000264.NC_007779.567537_567870.260	emrE.3000264.NC_007779.567537_567870.260	1	0	16	22	emrE_1	333	74	98.65	emrE_1.l15.c4.ctg.2	96	8.7	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	EmrE is a small multidrug transporter that functions as a homodimer and that couples the efflux of small polyaromatic cations from the cell with the import of protons down an electrochemical gradient. EmrE is found in E. coli and P. aeruginosa.;emrE
emrK.3000206.D78168.536_1592.173	emrK.3000206.D78168.536_1592.173	1	0	539	346	emrK	1056	1056	98.11	emrK.l6.c30.ctg.1	1636	16.0	0	.	p	.	0	P154T	NONSYN	460	462	CCA	723	725	ACA	16;17;18	A;C;A	16;17;18	.	emrK;emrK is a membrane fusion protein that is a homolog of EmrA. Together with the inner membrane transporter EmrY and the outer membrane channel TolC, it mediates multidrug efflux.
emrK.3000206.D78168.536_1592.173	emrK.3000206.D78168.536_1592.173	1	0	539	346	emrK	1056	1056	98.11	emrK.l6.c30.ctg.1	1636	16.0	0	.	p	.	0	K176R	NONSYN	526	528	AAG	789	791	AGG	15;16;16	A;G;G	15;15;16	.	emrK;emrK is a membrane fusion protein that is a homolog of EmrA. Together with the inner membrane transporter EmrY and the outer membrane channel TolC, it mediates multidrug efflux.
emrK.3000206.D78168.536_1592.173	emrK.3000206.D78168.536_1592.173	1	0	539	346	emrK	1056	1056	98.11	emrK.l6.c30.ctg.1	1636	16.0	0	.	p	.	0	N306D	NONSYN	916	918	AAC	1179	1181	GAC	12;12;12	G;A;C	12;12;12	.	emrK;emrK is a membrane fusion protein that is a homolog of EmrA. Together with the inner membrane transporter EmrY and the outer membrane channel TolC, it mediates multidrug efflux.
emrR.3000516.NC_000913.3.2810769_2811300.3621	emrR.3000516.NC_000913.3.2810769_2811300.3621	1	0	27	242	emrR	531	531	100.0	emrR.l15.c4.ctg.1	1156	15.3	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	EmrR is a negative regulator for the EmrAB-TolC multidrug efflux pump in E. coli. Mutations lead to EmrAB-TolC overexpression.;emrR
emrY.3000254.D78168.1591_3130.65	emrY.3000254.D78168.1591_3130.65	1	0	27	470	emrY	1539	1539	99.81	emrY.l6.c30.ctg.1	2056	16.8	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	emrY is a multidrug transport that moves substrates across the inner membrane of the Gram-negative E. coli. It is a homolog of emrB.;emrY
evgA.3000832.NC_002695.3211891_3212506.208	evgA.3000832.NC_002695.3211891_3212506.208	1	0	539	166	evgA	615	615	99.19	evgA.l6.c4.ctg.1	1059	11.7	0	.	p	.	0	Q62L	NONSYN	184	186	CAG	392	394	CTG	14;14;14	C;T;G	14;14;14	.	EvgA, when phosphorylated, is a positive regulator for efflux protein complexes emrKY and mdtEF. While usually phosphorylated in a EvgS dependent manner, it can be phosphorylated in the absence of EvgS when overexpressed.;evgA
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	994	evgS	3594	3594	97.55	evgS.l15.c4.ctg.1	3906	19.0	0	.	p	.	0	T38I	NONSYN	112	114	ACA	278	280	ATA	19;19;19	A;T;A	19;19;19	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	994	evgS	3594	3594	97.55	evgS.l15.c4.ctg.1	3906	19.0	0	.	p	.	0	L42V	NONSYN	124	126	CTA	290	292	GTA	16;15;15	G;T;A	15;15;15	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	994	evgS	3594	3594	97.55	evgS.l15.c4.ctg.1	3906	19.0	0	.	p	.	0	A93T	NONSYN	277	279	GCG	443	445	ACG	24;23;23	A;C;G	24;23;23	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	994	evgS	3594	3594	97.55	evgS.l15.c4.ctg.1	3906	19.0	0	.	p	.	0	A114E	NONSYN	340	342	GCA	506	508	GAA	15;15;16	G;A;A	15;15;16	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	994	evgS	3594	3594	97.55	evgS.l15.c4.ctg.1	3906	19.0	0	.	p	.	0	T127A	NONSYN	379	381	ACT	545	547	GCT	14;14;14	G;C;T	14;14;14	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	994	evgS	3594	3594	97.55	evgS.l15.c4.ctg.1	3906	19.0	0	.	p	.	0	N133D	NONSYN	397	399	AAT	563	565	GAT	13;13;13	G;A;T	13;13;13	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	994	evgS	3594	3594	97.55	evgS.l15.c4.ctg.1	3906	19.0	0	.	p	.	0	P162S	NONSYN	484	486	CCA	650	652	TCA	24;24;24	T;C;A	24;24;24	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	994	evgS	3594	3594	97.55	evgS.l15.c4.ctg.1	3906	19.0	0	.	p	.	0	H205Q	NONSYN	613	615	CAC	779	781	CAG	14;14;14	C;A;G	14;14;14	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	994	evgS	3594	3594	97.55	evgS.l15.c4.ctg.1	3906	19.0	0	.	p	.	0	I251V	NONSYN	751	753	ATT	917	919	GTT	11;11;11	G;T;T	11;11;11	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	994	evgS	3594	3594	97.55	evgS.l15.c4.ctg.1	3906	19.0	0	.	p	.	0	N303D	NONSYN	907	909	AAT	1073	1075	GAT	11;11;11	G;A;T	10;10;10	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	994	evgS	3594	3594	97.55	evgS.l15.c4.ctg.1	3906	19.0	0	.	p	.	0	S359N	NONSYN	1075	1077	AGC	1241	1243	AAT	7;7;7	A;A;T	7;7;7	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	994	evgS	3594	3594	97.55	evgS.l15.c4.ctg.1	3906	19.0	0	.	p	.	0	I366L	NONSYN	1096	1098	ATA	1262	1264	TTA	4;4;5	T;T;A	4;4;5	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	994	evgS	3594	3594	97.55	evgS.l15.c4.ctg.1	3906	19.0	0	.	p	.	0	Q433K	NONSYN	1297	1299	CAG	1463	1465	AAA	12;12;13	A;A;A	12;12;13	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	994	evgS	3594	3594	97.55	evgS.l15.c4.ctg.1	3906	19.0	0	.	p	.	0	N678H	NONSYN	2032	2034	AAT	2198	2200	CAT	25;26;26	C;A;T	25;26;26	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	994	evgS	3594	3594	97.55	evgS.l15.c4.ctg.1	3906	19.0	0	.	p	.	0	N696H	NONSYN	2086	2088	AAT	2252	2254	CAT	16;16;16	C;A;T	16;16;16	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	994	evgS	3594	3594	97.55	evgS.l15.c4.ctg.1	3906	19.0	0	.	p	.	0	K702R	NONSYN	2104	2106	AAA	2270	2272	AGA	14;12;12	A;G;A	14;12;12	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	994	evgS	3594	3594	97.55	evgS.l15.c4.ctg.1	3906	19.0	0	.	p	.	0	K707N	NONSYN	2119	2121	AAG	2285	2287	AAT	12;12;11	A;A;T	12;12;11	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	994	evgS	3594	3594	97.55	evgS.l15.c4.ctg.1	3906	19.0	0	.	p	.	0	A756S	NONSYN	2266	2268	GCC	2432	2434	TCC	17;17;17	T;C;C	17;17;17	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	994	evgS	3594	3594	97.55	evgS.l15.c4.ctg.1	3906	19.0	0	.	p	.	0	S811I	NONSYN	2431	2433	AGT	2597	2599	ATT	19;16;16	A;T;T	19;16;16	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	994	evgS	3594	3594	97.55	evgS.l15.c4.ctg.1	3906	19.0	0	.	p	.	0	E818D	NONSYN	2452	2454	GAA	2618	2620	GAT	15;15;15	G;A;T	15;15;15	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	994	evgS	3594	3594	97.55	evgS.l15.c4.ctg.1	3906	19.0	0	.	p	.	0	G856V	NONSYN	2566	2568	GGT	2732	2734	GTT	23;23;22	G;T;T	23;23;22	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	994	evgS	3594	3594	97.55	evgS.l15.c4.ctg.1	3906	19.0	0	.	p	.	0	Q951H	NONSYN	2851	2853	CAA	3017	3019	CAC	21;21;21	C;A;C	21;21;21	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
folP.3003386.NC_007779.3323917_3324766.2056	folP.3003386.NC_007779.3323917_3324766.2056	1	1	27	360	folP_1	849	849	99.29	folP_1.l15.c4.ctg.1	1351	19.7	1	SNP	p	P64S	0	.	.	190	192	CCA	439	441	CCA	35;36;36	C;C;A	35;36;36	folP.3003386.NC_007779.3323917_3324766.2056:1:1:P64S:.:Point mutations in Escherichia coli dihydropteroate synthase folP prevent sulfonamide antibiotics from inhibiting its role in folate synthesis, thus conferring sulfonamide resistance.	Escherichia coli sulfonamide resistant mutant folP
folP.3003386.NC_007779.3323917_3324766.2056	folP.3003386.NC_007779.3323917_3324766.2056	1	1	27	360	folP_1	849	849	99.29	folP_1.l15.c4.ctg.1	1351	19.7	1	SNP	p	P64A	0	.	.	190	192	CCA	439	441	CCA	35;36;36	C;C;A	35;36;36	folP.3003386.NC_007779.3323917_3324766.2056:1:1:P64A:.:Point mutations in Escherichia coli dihydropteroate synthase folP prevent sulfonamide antibiotics from inhibiting its role in folate synthesis, thus conferring sulfonamide resistance.	Escherichia coli sulfonamide resistant mutant folP
folP.3003386.NC_007779.3323917_3324766.2056	folP.3003386.NC_007779.3323917_3324766.2056	1	1	27	360	folP_1	849	849	99.29	folP_1.l15.c4.ctg.1	1351	19.7	1	SNP	p	P64H	0	.	.	190	192	CCA	439	441	CCA	35;36;36	C;C;A	35;36;36	folP.3003386.NC_007779.3323917_3324766.2056:1:1:P64H:.:Point mutations in Escherichia coli dihydropteroate synthase folP prevent sulfonamide antibiotics from inhibiting its role in folate synthesis, thus conferring sulfonamide resistance.	Escherichia coli sulfonamide resistant mutant folP
folP.3003386.NC_007779.3323917_3324766.2056	folP.3003386.NC_007779.3323917_3324766.2056	1	1	27	360	folP_1	849	849	99.29	folP_1.l15.c4.ctg.1	1351	19.7	1	SNP	p	P64L	0	.	.	190	192	CCA	439	441	CCA	35;36;36	C;C;A	35;36;36	folP.3003386.NC_007779.3323917_3324766.2056:1:1:P64L:.:Point mutations in Escherichia coli dihydropteroate synthase folP prevent sulfonamide antibiotics from inhibiting its role in folate synthesis, thus conferring sulfonamide resistance.	Escherichia coli sulfonamide resistant mutant folP
folP.3003386.NC_007779.3323917_3324766.2056	folP.3003386.NC_007779.3323917_3324766.2056	1	1	27	360	folP_1	849	849	99.29	folP_1.l15.c4.ctg.1	1351	19.7	1	SNP	p	P64R	0	.	.	190	192	CCA	439	441	CCA	35;36;36	C;C;A	35;36;36	folP.3003386.NC_007779.3323917_3324766.2056:1:1:P64R:.:Point mutations in Escherichia coli dihydropteroate synthase folP prevent sulfonamide antibiotics from inhibiting its role in folate synthesis, thus conferring sulfonamide resistance.	Escherichia coli sulfonamide resistant mutant folP
gadE.3003834.NC_000913.3.3658365_3658893.3597	gadE.3003834.NC_000913.3.3658365_3658893.3597	1	0	27	166	gadE	528	528	100.0	gadE.l15.c4.ctg.1	1089	11.2	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	gadE;gadE is a DNA-binding transcriptional activator that regulates the expression of genes involved in acid resistance. It is required for the expression of gadA and gadBC.
gadW.3003838.CP015085.1.2551711_2552440.3599	gadW.3003838.CP015085.1.2551711_2552440.3599	1	0	512	72	gadW	729	381	95.8	gadW.l15.c4.ctg.1	563	8.6	0	.	p	.	0	S234A	NONSYN	700	702	TCG	352	354	GCG	8;8;9	G;C;G	8;8;9	.	gadW;GadW is an AraC-family regulator that promotes mdtEF expression to confer multidrug resistance. GadW inhibits GadX-dependent activation. GadW clearly represses gadX and, in situations where GadX is missing, activates gadA and gadBC.
gadW.3003838.CP015085.1.2551711_2552440.3599	gadW.3003838.CP015085.1.2551711_2552440.3599	1	0	512	72	gadW	729	149	93.29	gadW.l15.c4.ctg.2	162	2.8	0	.	p	.	0	E54D	NONSYN	160	162	GAA	13	15	GAT	1;1;1	G;A;T	1;1;1	.	gadW;GadW is an AraC-family regulator that promotes mdtEF expression to confer multidrug resistance. GadW inhibits GadX-dependent activation. GadW clearly represses gadX and, in situations where GadX is missing, activates gadA and gadBC.
gadW.3003838.CP015085.1.2551711_2552440.3599	gadW.3003838.CP015085.1.2551711_2552440.3599	1	0	512	72	gadW	729	149	93.29	gadW.l15.c4.ctg.2	162	2.8	0	.	p	.	0	I88M	NONSYN	262	264	ATA	115	117	ATG	4;4;4	A;T;G	4;4;4	.	gadW;GadW is an AraC-family regulator that promotes mdtEF expression to confer multidrug resistance. GadW inhibits GadX-dependent activation. GadW clearly represses gadX and, in situations where GadX is missing, activates gadA and gadBC.
gadW.3003838.CP015085.1.2551711_2552440.3599	gadW.3003838.CP015085.1.2551711_2552440.3599	1	0	512	72	gadW	729	149	93.29	gadW.l15.c4.ctg.2	162	2.8	0	.	p	.	0	Q89P	NONSYN	265	267	CAG	118	120	CCG	4;4;4	C;C;G	4;4;4	.	gadW;GadW is an AraC-family regulator that promotes mdtEF expression to confer multidrug resistance. GadW inhibits GadX-dependent activation. GadW clearly represses gadX and, in situations where GadX is missing, activates gadA and gadBC.
gadX.3000508.NC_007779.3974604_3975429.615	gadX.3000508.NC_007779.3974604_3975429.615	1	0	539	202	gadX	825	825	97.94	gadX.l15.c17.ctg.1	1072	13.9	0	.	p	.	0	F53L	NONSYN	157	159	TTC	333	335	TTA	12;12;13	T;T;A	12;12;13	.	GadX is an AraC-family regulator that promotes mdtEF expression to confer multidrug resistance.;gadX
gadX.3000508.NC_007779.3974604_3975429.615	gadX.3000508.NC_007779.3974604_3975429.615	1	0	539	202	gadX	825	825	97.94	gadX.l15.c17.ctg.1	1072	13.9	0	.	p	.	0	V79I	NONSYN	235	237	GTT	411	413	ATT	13;13;13	A;T;T	13;13;13	.	GadX is an AraC-family regulator that promotes mdtEF expression to confer multidrug resistance.;gadX
gadX.3000508.NC_007779.3974604_3975429.615	gadX.3000508.NC_007779.3974604_3975429.615	1	0	539	202	gadX	825	825	97.94	gadX.l15.c17.ctg.1	1072	13.9	0	.	p	.	0	R246G	NONSYN	736	738	AGA	912	914	GGA	12;12;12	G;G;A	12;12;12	.	GadX is an AraC-family regulator that promotes mdtEF expression to confer multidrug resistance.;gadX
gadX.3000508.NC_007779.3974604_3975429.615	gadX.3000508.NC_007779.3974604_3975429.615	1	0	539	202	gadX	825	825	97.94	gadX.l15.c17.ctg.1	1072	13.9	0	.	p	.	0	S248P	NONSYN	742	744	TCG	918	920	CCG	12;12;12	C;C;G	12;12;12	.	GadX is an AraC-family regulator that promotes mdtEF expression to confer multidrug resistance.;gadX
gyrA.3003294.U00096.2336792_2339420.2052	gyrA.3003294.U00096.2336792_2339420.2052	1	1	539	1256	gyrA_7	2628	2628	98.71	gyrA_7.l6.c30.ctg.1	3138	30.0	0	.	p	.	0	D678E	NONSYN	2032	2034	GAC	2314	2316	GAA	24;25;25	G;A;A	24;25;25	.	Escherichia coli gyrA conferring resistance to fluoroquinolones
gyrA.3003294.U00096.2336792_2339420.2052	gyrA.3003294.U00096.2336792_2339420.2052	1	1	539	1256	gyrA_7	2628	2628	98.71	gyrA_7.l6.c30.ctg.1	3138	30.0	1	SNP	p	S83I	0	.	.	247	249	TCG	529	531	TCG	37;38;38	T;C;G	37;38;38	gyrA.3003294.U00096.2336792_2339420.2052:1:1:S83I:.:Point mutation of Escherichia coli gyrA resulted in the lowered affinity between fluoroquinolones and gyrA. Thus, conferring resistance	Escherichia coli gyrA conferring resistance to fluoroquinolones
gyrA.3003294.U00096.2336792_2339420.2052	gyrA.3003294.U00096.2336792_2339420.2052	1	1	539	1256	gyrA_7	2628	2628	98.71	gyrA_7.l6.c30.ctg.1	3138	30.0	1	SNP	p	S83L	0	.	.	247	249	TCG	529	531	TCG	37;38;38	T;C;G	37;38;38	gyrA.3003294.U00096.2336792_2339420.2052:1:1:S83L:.:Point mutation of Escherichia coli gyrA resulted in the lowered affinity between fluoroquinolones and gyrA. Thus, conferring resistance	Escherichia coli gyrA conferring resistance to fluoroquinolones
gyrA.3003294.U00096.2336792_2339420.2052	gyrA.3003294.U00096.2336792_2339420.2052	1	1	539	1256	gyrA_7	2628	2628	98.71	gyrA_7.l6.c30.ctg.1	3138	30.0	1	SNP	p	S83W	0	.	.	247	249	TCG	529	531	TCG	37;38;38	T;C;G	37;38;38	gyrA.3003294.U00096.2336792_2339420.2052:1:1:S83W:.:Point mutation of Escherichia coli gyrA resulted in the lowered affinity between fluoroquinolones and gyrA. Thus, conferring resistance	Escherichia coli gyrA conferring resistance to fluoroquinolones
gyrA.3003294.U00096.2336792_2339420.2052	gyrA.3003294.U00096.2336792_2339420.2052	1	1	539	1256	gyrA_7	2628	2628	98.71	gyrA_7.l6.c30.ctg.1	3138	30.0	1	SNP	p	D87H	0	.	.	259	261	GAC	541	543	GAC	37;36;36	G;A;C	36;36;36	gyrA.3003294.U00096.2336792_2339420.2052:1:1:D87H:.:Point mutation of Escherichia coli gyrA resulted in the lowered affinity between fluoroquinolones and gyrA. Thus, conferring resistance	Escherichia coli gyrA conferring resistance to fluoroquinolones
gyrA.3003294.U00096.2336792_2339420.2052	gyrA.3003294.U00096.2336792_2339420.2052	1	1	539	1256	gyrA_7	2628	2628	98.71	gyrA_7.l6.c30.ctg.1	3138	30.0	1	SNP	p	D87G	0	.	.	259	261	GAC	541	543	GAC	37;36;36	G;A;C	36;36;36	gyrA.3003294.U00096.2336792_2339420.2052:1:1:D87G:.:Point mutation of Escherichia coli gyrA resulted in the lowered affinity between fluoroquinolones and gyrA. Thus, conferring resistance	Escherichia coli gyrA conferring resistance to fluoroquinolones
gyrA.3003294.U00096.2336792_2339420.2052	gyrA.3003294.U00096.2336792_2339420.2052	1	1	539	1256	gyrA_7	2628	2628	98.71	gyrA_7.l6.c30.ctg.1	3138	30.0	1	SNP	p	D87Y	0	.	.	259	261	GAC	541	543	GAC	37;36;36	G;A;C	36;36;36	gyrA.3003294.U00096.2336792_2339420.2052:1:1:D87Y:.:Point mutation of Escherichia coli gyrA resulted in the lowered affinity between fluoroquinolones and gyrA. Thus, conferring resistance	Escherichia coli gyrA conferring resistance to fluoroquinolones
gyrA.3003294.U00096.2336792_2339420.2052	gyrA.3003294.U00096.2336792_2339420.2052	1	1	539	1256	gyrA_7	2628	2628	98.71	gyrA_7.l6.c30.ctg.1	3138	30.0	1	SNP	p	D87V	0	.	.	259	261	GAC	541	543	GAC	37;36;36	G;A;C	36;36;36	gyrA.3003294.U00096.2336792_2339420.2052:1:1:D87V:.:Point mutation of Escherichia coli gyrA resulted in the lowered affinity between fluoroquinolones and gyrA. Thus, conferring resistance	Escherichia coli gyrA conferring resistance to fluoroquinolones
gyrA.3003294.U00096.2336792_2339420.2052	gyrA.3003294.U00096.2336792_2339420.2052	1	1	539	1256	gyrA_7	2628	2628	98.71	gyrA_7.l6.c30.ctg.1	3138	30.0	1	SNP	p	D87N	0	.	.	259	261	GAC	541	543	GAC	37;36;36	G;A;C	36;36;36	gyrA.3003294.U00096.2336792_2339420.2052:1:1:D87N:.:Point mutation of Escherichia coli gyrA resulted in the lowered affinity between fluoroquinolones and gyrA. Thus, conferring resistance	Escherichia coli gyrA conferring resistance to fluoroquinolones
gyrB.3003303.AP009048.3760295_3762710.2063	gyrB.3003303.AP009048.3760295_3762710.2063	1	1	27	1092	gyrB_1	2415	2415	99.05	gyrB_1.l6.c17.ctg.1	3017	27.2	1	SNP	p	R136G	0	.	.	406	408	CGC	655	657	CGC	29;29;29	C;G;C	29;29;28	gyrB.3003303.AP009048.3760295_3762710.2063:1:1:R136G:.:Point mutation in Escherichia coli resulting in aminocoumarin resistance	Escherichia coli gyrB conferring resistance to aminocoumarin
gyrB.3003303.AP009048.3760295_3762710.2063	gyrB.3003303.AP009048.3760295_3762710.2063	1	1	27	1092	gyrB_1	2415	2415	99.05	gyrB_1.l6.c17.ctg.1	3017	27.2	1	SNP	p	R136C	0	.	.	406	408	CGC	655	657	CGC	29;29;29	C;G;C	29;29;28	gyrB.3003303.AP009048.3760295_3762710.2063:1:1:R136C:.:Point mutation in Escherichia coli resulting in aminocoumarin resistance	Escherichia coli gyrB conferring resistance to aminocoumarin
gyrB.3003303.AP009048.3760295_3762710.2063	gyrB.3003303.AP009048.3760295_3762710.2063	1	1	27	1092	gyrB_1	2415	2415	99.05	gyrB_1.l6.c17.ctg.1	3017	27.2	1	SNP	p	R136S	0	.	.	406	408	CGC	655	657	CGC	29;29;29	C;G;C	29;29;28	gyrB.3003303.AP009048.3760295_3762710.2063:1:1:R136S:.:Point mutation in Escherichia coli resulting in aminocoumarin resistance	Escherichia coli gyrB conferring resistance to aminocoumarin
gyrB.3003303.AP009048.3760295_3762710.2063	gyrB.3003303.AP009048.3760295_3762710.2063	1	1	27	1092	gyrB_1	2415	2415	99.05	gyrB_1.l6.c17.ctg.1	3017	27.2	1	SNP	p	R136I	0	.	.	406	408	CGC	655	657	CGC	29;29;29	C;G;C	29;29;28	gyrB.3003303.AP009048.3760295_3762710.2063:1:1:R136I:.:Point mutation in Escherichia coli resulting in aminocoumarin resistance	Escherichia coli gyrB conferring resistance to aminocoumarin
gyrB.3003303.AP009048.3760295_3762710.2063	gyrB.3003303.AP009048.3760295_3762710.2063	1	1	27	1092	gyrB_1	2415	2415	99.05	gyrB_1.l6.c17.ctg.1	3017	27.2	1	SNP	p	R136E	0	.	.	406	408	CGC	655	657	CGC	29;29;29	C;G;C	29;29;28	gyrB.3003303.AP009048.3760295_3762710.2063:1:1:R136E:.:Point mutation in Escherichia coli resulting in aminocoumarin resistance	Escherichia coli gyrB conferring resistance to aminocoumarin
gyrB.3003303.AP009048.3760295_3762710.2063	gyrB.3003303.AP009048.3760295_3762710.2063	1	1	27	1092	gyrB_1	2415	2415	99.05	gyrB_1.l6.c17.ctg.1	3017	27.2	1	SNP	p	R136L	0	.	.	406	408	CGC	655	657	CGC	29;29;29	C;G;C	29;29;28	gyrB.3003303.AP009048.3760295_3762710.2063:1:1:R136L:.:Point mutation in Escherichia coli resulting in aminocoumarin resistance	Escherichia coli gyrB conferring resistance to aminocoumarin
gyrB.3003303.AP009048.3760295_3762710.2063	gyrB.3003303.AP009048.3760295_3762710.2063	1	1	27	1092	gyrB_1	2415	2415	99.05	gyrB_1.l6.c17.ctg.1	3017	27.2	1	SNP	p	R136H	0	.	.	406	408	CGC	655	657	CGC	29;29;29	C;G;C	29;29;28	gyrB.3003303.AP009048.3760295_3762710.2063:1:1:R136H:.:Point mutation in Escherichia coli resulting in aminocoumarin resistance	Escherichia coli gyrB conferring resistance to aminocoumarin
kdpE.3003841.NC_000913.3.721055_721733.3608	kdpE.3003841.NC_000913.3.721055_721733.3608	1	0	539	218	kdpE	678	678	98.23	kdpE.l15.c30.ctg.1	1157	14.3	0	.	p	.	0	A72P	NONSYN	214	216	GCG	517	519	CCG	22;23;23	C;C;G	22;23;23	.	kdpE;kdpE is a transcriptional activator that is part of the two-component system KdpD/KdpE that is studied for its regulatory role in potassium transport and has been identified as an adaptive regulator involved in the virulence and intracellular survival of pathogenic bacteria. kdpE regulates a range of virulence loci through direct promoter binding.
kdpE.3003841.NC_000913.3.721055_721733.3608	kdpE.3003841.NC_000913.3.721055_721733.3608	1	0	539	218	kdpE	678	678	98.23	kdpE.l15.c30.ctg.1	1157	14.3	0	.	p	.	0	T123A	NONSYN	367	369	ACC	670	672	GCC	24;23;23	G;C;C	23;23;23	.	kdpE;kdpE is a transcriptional activator that is part of the two-component system KdpD/KdpE that is studied for its regulatory role in potassium transport and has been identified as an adaptive regulator involved in the virulence and intracellular survival of pathogenic bacteria. kdpE regulates a range of virulence loci through direct promoter binding.
leuO.3003843.NC_000913.3.84367_85312.3607	leuO.3003843.NC_000913.3.84367_85312.3607	1	0	539	362	leuO	945	945	99.26	leuO.l15.c30.ctg.1	1422	19.1	0	.	p	.	0	P9S	NONSYN	25	27	CCA	265	267	TCA	20;19;19	T;C;A	19;19;19	.	leuO, a LysR family transcription factor, exists in a wide variety of bacteria of the family Enterobacteriaceae and is involved in the regulation of as yet unidentified genes affecting the stress response and pathogenesis expression.;leuO
marA.3000263.NC_007779.1621287_1621671.579	marA.3000263.NC_007779.1621287_1621671.579	1	0	27	156	marA	384	384	99.74	marA.l15.c4.ctg.1	921	12.6	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	In the presence of antibiotic stress, E. coli overexpresses the global activator protein MarA, which besides inducing MDR efflux pump AcrAB, also down- regulates synthesis of the porin OmpF.;marA
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	539	100	marR	435	435	97.7	marR.l6.c30.ctg.1	1016	7.4	1	SNP	p	G103S	1	G103S	NONSYN	307	309	GGC	536	538	AGC	14;14;15	A;G;C	13;13;14	marR.3003378.U00096.1619119_1619554.2097:1:1:G103S:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	539	100	marR	435	435	97.7	marR.l6.c30.ctg.1	1016	7.4	1	SNP	p	Y137H	1	Y137H	NONSYN	409	411	TAT	638	640	CAT	6;6;6	C;A;T	6;6;6	marR.3003378.U00096.1619119_1619554.2097:1:1:Y137H:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	539	100	marR	435	435	97.7	marR.l6.c30.ctg.1	1016	7.4	1	SNP	p	V45E	0	.	.	133	135	GTG	362	364	GTG	13;12;12	G;T;G	13;12;12	marR.3003378.U00096.1619119_1619554.2097:1:1:V45E:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	539	100	marR	435	435	97.7	marR.l6.c30.ctg.1	1016	7.4	1	SNP	p	I49S	0	.	.	145	147	ATC	374	376	ATC	13;13;13	A;T;C	13;13;13	marR.3003378.U00096.1619119_1619554.2097:1:1:I49S:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	539	100	marR	435	435	97.7	marR.l6.c30.ctg.1	1016	7.4	1	SNP	p	A70T	0	.	.	208	210	GCA	437	439	GCA	13;14;14	G;C;A	13;14;14	marR.3003378.U00096.1619119_1619554.2097:1:1:A70T:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	539	100	marR	435	435	97.7	marR.l6.c30.ctg.1	1016	7.4	1	SNP	p	R73S	0	.	.	217	219	CGT	446	448	CGT	13;14;14	C;G;T	13;13;13	marR.3003378.U00096.1619119_1619554.2097:1:1:R73S:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	539	100	marR	435	435	97.7	marR.l6.c30.ctg.1	1016	7.4	1	SNP	p	R73C	0	.	.	217	219	CGT	446	448	CGT	13;14;14	C;G;T	13;13;13	marR.3003378.U00096.1619119_1619554.2097:1:1:R73C:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	539	100	marR	435	435	97.7	marR.l6.c30.ctg.1	1016	7.4	1	SNP	p	R77C	0	.	.	229	231	CGC	458	460	CGC	13;13;12	C;G;C	13;13;12	marR.3003378.U00096.1619119_1619554.2097:1:1:R77C:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	539	100	marR	435	435	97.7	marR.l6.c30.ctg.1	1016	7.4	1	SNP	p	R77L	0	.	.	229	231	CGC	458	460	CGC	13;13;12	C;G;C	13;13;12	marR.3003378.U00096.1619119_1619554.2097:1:1:R77L:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	539	100	marR	435	435	97.7	marR.l6.c30.ctg.1	1016	7.4	1	SNP	p	L78M	0	.	.	232	234	CTG	461	463	CTG	12;12;12	C;T;G	12;12;12	marR.3003378.U00096.1619119_1619554.2097:1:1:L78M:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	539	100	marR	435	435	97.7	marR.l6.c30.ctg.1	1016	7.4	1	SNP	p	R94H	0	.	.	280	282	CGC	509	511	CGC	14;12;12	C;G;C	14;11;11	marR.3003378.U00096.1619119_1619554.2097:1:1:R94H:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	539	100	marR	435	435	97.7	marR.l6.c30.ctg.1	1016	7.4	1	SNP	p	R94S	0	.	.	280	282	CGC	509	511	CGC	14;12;12	C;G;C	14;11;11	marR.3003378.U00096.1619119_1619554.2097:1:1:R94S:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	539	100	marR	435	435	97.7	marR.l6.c30.ctg.1	1016	7.4	1	SNP	p	V96E	0	.	.	286	288	GTA	515	517	GTA	11;11;11	G;T;A	11;11;11	marR.3003378.U00096.1619119_1619554.2097:1:1:V96E:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
mdfA.3001328.JQ394987.0_1233.561	mdfA.3001328.JQ394987.0_1233.561	1	0	531	374	mdfA	1233	1233	97.0	mdfA.l6.c17.ctg.1	1468	18.8	0	.	p	.	0	S7F	NONSYN	19	21	TCC	101	103	TTC	9;8;8	T;T;C	9;8;8	.	Multidrug translocase MdfA;mdfA
mdfA.3001328.JQ394987.0_1233.561	mdfA.3001328.JQ394987.0_1233.561	1	0	531	374	mdfA	1233	1233	97.0	mdfA.l6.c17.ctg.1	1468	18.8	0	.	p	.	0	R36I	NONSYN	106	108	AGG	188	190	ATC	4;4;4	A;T;C	4;4;4	.	Multidrug translocase MdfA;mdfA
mdfA.3001328.JQ394987.0_1233.561	mdfA.3001328.JQ394987.0_1233.561	1	0	531	374	mdfA	1233	1233	97.0	mdfA.l6.c17.ctg.1	1468	18.8	0	.	p	.	0	E42A	NONSYN	124	126	GAA	206	208	GCC	4;4;4	G;C;C	4;4;4	.	Multidrug translocase MdfA;mdfA
mdfA.3001328.JQ394987.0_1233.561	mdfA.3001328.JQ394987.0_1233.561	1	0	531	374	mdfA	1233	1233	97.0	mdfA.l6.c17.ctg.1	1468	18.8	0	.	p	.	0	N43V	NONSYN	127	129	AAT	209	211	GTG	4;4;4	G;T;G	4;4;4	.	Multidrug translocase MdfA;mdfA
mdfA.3001328.JQ394987.0_1233.561	mdfA.3001328.JQ394987.0_1233.561	1	0	531	374	mdfA	1233	1233	97.0	mdfA.l6.c17.ctg.1	1468	18.8	0	.	p	.	0	E52D	NONSYN	154	156	GAG	236	238	GAT	2;3;3	G;A;T	2;3;3	.	Multidrug translocase MdfA;mdfA
mdfA.3001328.JQ394987.0_1233.561	mdfA.3001328.JQ394987.0_1233.561	1	0	531	374	mdfA	1233	1233	97.0	mdfA.l6.c17.ctg.1	1468	18.8	0	.	p	.	0	N59T	NONSYN	175	177	AAC	257	259	ACC	10;10;10	A;C;C	10;10;10	.	Multidrug translocase MdfA;mdfA
mdfA.3001328.JQ394987.0_1233.561	mdfA.3001328.JQ394987.0_1233.561	1	0	531	374	mdfA	1233	1233	97.0	mdfA.l6.c17.ctg.1	1468	18.8	0	.	p	.	0	I68L	NONSYN	202	204	ATA	284	286	TTA	10;10;11	T;T;A	10;10;11	.	Multidrug translocase MdfA;mdfA
mdfA.3001328.JQ394987.0_1233.561	mdfA.3001328.JQ394987.0_1233.561	1	0	531	374	mdfA	1233	1233	97.0	mdfA.l6.c17.ctg.1	1468	18.8	0	.	p	.	0	H115Q	NONSYN	343	345	CAC	425	427	CAG	26;26;26	C;A;G	26;26;26	.	Multidrug translocase MdfA;mdfA
mdfA.3001328.JQ394987.0_1233.561	mdfA.3001328.JQ394987.0_1233.561	1	0	531	374	mdfA	1233	1233	97.0	mdfA.l6.c17.ctg.1	1468	18.8	0	.	p	.	0	D128A	NONSYN	382	384	GAC	464	466	GCC	36;36;36	G;C;C	36;36;35	.	Multidrug translocase MdfA;mdfA
mdfA.3001328.JQ394987.0_1233.561	mdfA.3001328.JQ394987.0_1233.561	1	0	531	374	mdfA	1233	1233	97.0	mdfA.l6.c17.ctg.1	1468	18.8	0	.	p	.	0	S163A	NONSYN	487	489	TCG	569	571	GCG	35;35;36	G;C;G	33;33;35	.	Multidrug translocase MdfA;mdfA
mdfA.3001328.JQ394987.0_1233.561	mdfA.3001328.JQ394987.0_1233.561	1	0	531	374	mdfA	1233	1233	97.0	mdfA.l6.c17.ctg.1	1468	18.8	0	.	p	.	0	L231V	NONSYN	691	693	CTT	773	775	GTT	25;26;25	G;T;T	25;25;24	.	Multidrug translocase MdfA;mdfA
mdfA.3001328.JQ394987.0_1233.561	mdfA.3001328.JQ394987.0_1233.561	1	0	531	374	mdfA	1233	1233	97.0	mdfA.l6.c17.ctg.1	1468	18.8	0	.	p	.	0	R285fs	FSHIFT	853	853	C	935	935	C	18	C	18	.	Multidrug translocase MdfA;mdfA
mdtA.3000792.U00096.2154015_2155263.15	mdtA.3000792.U00096.2154015_2155263.15	1	0	539	356	mdtA	1248	1248	97.44	mdtA.l15.c4.ctg.1	1668	16.0	0	.	p	.	0	V12trunc	TRUNC	34	34	G	221	221	G	12	G	12	.	mdtA;MdtA is the membrane fusion protein of the multidrug efflux complex mdtABC.
mdtA.3000792.U00096.2154015_2155263.15	mdtA.3000792.U00096.2154015_2155263.15	1	0	539	356	mdtA	1248	1248	97.44	mdtA.l15.c4.ctg.1	1668	16.0	0	.	p	.	0	R33Q	NONSYN	97	99	CGG	278	280	CAG	7;7;6	C;A;G	7;7;6	.	mdtA;MdtA is the membrane fusion protein of the multidrug efflux complex mdtABC.
mdtA.3000792.U00096.2154015_2155263.15	mdtA.3000792.U00096.2154015_2155263.15	1	0	539	356	mdtA	1248	1248	97.44	mdtA.l15.c4.ctg.1	1668	16.0	0	.	p	.	0	T83I	NONSYN	247	249	ACC	428	430	ATC	7;7;8	A;T;C	7;6;8	.	mdtA;MdtA is the membrane fusion protein of the multidrug efflux complex mdtABC.
mdtA.3000792.U00096.2154015_2155263.15	mdtA.3000792.U00096.2154015_2155263.15	1	0	539	356	mdtA	1248	1248	97.44	mdtA.l15.c4.ctg.1	1668	16.0	0	.	p	.	0	I99M	NONSYN	295	297	ATA	476	478	ATG	10;10;10	A;T;G	10;10;10	.	mdtA;MdtA is the membrane fusion protein of the multidrug efflux complex mdtABC.
mdtA.3000792.U00096.2154015_2155263.15	mdtA.3000792.U00096.2154015_2155263.15	1	0	539	356	mdtA	1248	1248	97.44	mdtA.l15.c4.ctg.1	1668	16.0	0	.	p	.	0	A130T	NONSYN	388	390	GCC	569	571	ACC	13;13;13	A;C;C	13;13;13	.	mdtA;MdtA is the membrane fusion protein of the multidrug efflux complex mdtABC.
mdtB.3000793.U00096.2155262_2158385.215	mdtB.3000793.U00096.2155262_2158385.215	1	0	539	1344	mdtB	3123	3123	98.94	mdtB.l15.c4.ctg.1	3707	27.3	0	.	p	.	0	A583T	NONSYN	1747	1749	GCC	2059	2061	ACC	31;32;31	A;C;C	30;31;30	.	mdtB;MdtB is a transporter that forms a heteromultimer complex with MdtC to form a multidrug transporter. MdtBC is part of the MdtABC-TolC efflux complex.
mdtB.3000793.U00096.2155262_2158385.215	mdtB.3000793.U00096.2155262_2158385.215	1	0	539	1344	mdtB	3123	3123	98.94	mdtB.l15.c4.ctg.1	3707	27.3	0	.	p	.	0	V611I	NONSYN	1831	1833	GTT	2143	2145	ATT	27;27;27	A,G;T;T	25,2;26;27	.	mdtB;MdtB is a transporter that forms a heteromultimer complex with MdtC to form a multidrug transporter. MdtBC is part of the MdtABC-TolC efflux complex.
mdtB.3000793.U00096.2155262_2158385.215	mdtB.3000793.U00096.2155262_2158385.215	1	0	539	1344	mdtB	3123	3123	98.94	mdtB.l15.c4.ctg.1	3707	27.3	0	.	p	.	0	K714Q	NONSYN	2140	2142	AAA	2452	2454	CAA	32;30;31	C;A;A	31;30;31	.	mdtB;MdtB is a transporter that forms a heteromultimer complex with MdtC to form a multidrug transporter. MdtBC is part of the MdtABC-TolC efflux complex.
mdtB.3000793.U00096.2155262_2158385.215	mdtB.3000793.U00096.2155262_2158385.215	1	0	539	1344	mdtB	3123	3123	98.94	mdtB.l15.c4.ctg.1	3707	27.3	0	.	p	.	0	N770I	NONSYN	2308	2310	AAT	2620	2622	ATT	27;28;28	A;T;T	27;28;28	.	mdtB;MdtB is a transporter that forms a heteromultimer complex with MdtC to form a multidrug transporter. MdtBC is part of the MdtABC-TolC efflux complex.
mdtB.3000793.U00096.2155262_2158385.215	mdtB.3000793.U00096.2155262_2158385.215	1	0	539	1344	mdtB	3123	3123	98.94	mdtB.l15.c4.ctg.1	3707	27.3	0	.	p	.	0	I798V	NONSYN	2392	2394	ATT	2704	2706	GTT	24;24;24	G;T;T	24;24;24	.	mdtB;MdtB is a transporter that forms a heteromultimer complex with MdtC to form a multidrug transporter. MdtBC is part of the MdtABC-TolC efflux complex.
mdtB.3000793.U00096.2155262_2158385.215	mdtB.3000793.U00096.2155262_2158385.215	1	0	539	1344	mdtB	3123	3123	98.94	mdtB.l15.c4.ctg.1	3707	27.3	0	.	p	.	0	A834E	NONSYN	2500	2502	GCG	2812	2814	GAG	24;25;25	G;A;G	24;24;24	.	mdtB;MdtB is a transporter that forms a heteromultimer complex with MdtC to form a multidrug transporter. MdtBC is part of the MdtABC-TolC efflux complex.
mdtB.3000793.U00096.2155262_2158385.215	mdtB.3000793.U00096.2155262_2158385.215	1	0	539	1344	mdtB	3123	3123	98.94	mdtB.l15.c4.ctg.1	3707	27.3	0	.	p	.	0	L910M	NONSYN	2728	2730	CTG	3040	3042	ATG	23;23;23	A;T;G	23;23;23	.	mdtB;MdtB is a transporter that forms a heteromultimer complex with MdtC to form a multidrug transporter. MdtBC is part of the MdtABC-TolC efflux complex.
mdtB.3000793.U00096.2155262_2158385.215	mdtB.3000793.U00096.2155262_2158385.215	1	0	539	1344	mdtB	3123	3123	98.94	mdtB.l15.c4.ctg.1	3707	27.3	0	.	p	.	0	E955D	NONSYN	2863	2865	GAG	3175	3177	GAT	21;20;20	G;A;T	21;20;19	.	mdtB;MdtB is a transporter that forms a heteromultimer complex with MdtC to form a multidrug transporter. MdtBC is part of the MdtABC-TolC efflux complex.
mdtC.3000794.U00096.2158385_2161463.257	mdtC.3000794.U00096.2158385_2161463.257	1	0	539	1184	mdtC	3078	3078	98.64	mdtC.l15.c4.ctg.1	3570	25.0	0	.	p	.	0	I46M	NONSYN	136	138	ATC	380	382	ATG	15;15;15	A;T;G	14;15;12	.	MdtC is a transporter that forms a heteromultimer complex with MdtB to form a multidrug transporter. MdtBC is part of the MdtABC-TolC efflux complex. In the absence of MdtB, MdtC can form a homomultimer complex that results in a functioning efflux complex with a narrower drug specificity.;mdtC
mdtC.3000794.U00096.2158385_2161463.257	mdtC.3000794.U00096.2158385_2161463.257	1	0	539	1184	mdtC	3078	3078	98.64	mdtC.l15.c4.ctg.1	3570	25.0	0	.	p	.	0	V208I	NONSYN	622	624	GTC	866	868	ATC	41;41;40	A;T;C	40;41;40	.	MdtC is a transporter that forms a heteromultimer complex with MdtB to form a multidrug transporter. MdtBC is part of the MdtABC-TolC efflux complex. In the absence of MdtB, MdtC can form a homomultimer complex that results in a functioning efflux complex with a narrower drug specificity.;mdtC
mdtC.3000794.U00096.2158385_2161463.257	mdtC.3000794.U00096.2158385_2161463.257	1	0	539	1184	mdtC	3078	3078	98.64	mdtC.l15.c4.ctg.1	3570	25.0	0	.	p	.	0	Q980H	NONSYN	2938	2940	CAA	3182	3184	CAC	18;17;17	C;A;C	17;16;16	.	MdtC is a transporter that forms a heteromultimer complex with MdtB to form a multidrug transporter. MdtBC is part of the MdtABC-TolC efflux complex. In the absence of MdtB, MdtC can form a homomultimer complex that results in a functioning efflux complex with a narrower drug specificity.;mdtC
mdtC.3000794.U00096.2158385_2161463.257	mdtC.3000794.U00096.2158385_2161463.257	1	0	539	1184	mdtC	3078	3078	98.64	mdtC.l15.c4.ctg.1	3570	25.0	0	.	p	.	0	P981L	NONSYN	2941	2943	CCC	3185	3187	CTC	17;17;18	C;T;C	16;16;17	.	MdtC is a transporter that forms a heteromultimer complex with MdtB to form a multidrug transporter. MdtBC is part of the MdtABC-TolC efflux complex. In the absence of MdtB, MdtC can form a homomultimer complex that results in a functioning efflux complex with a narrower drug specificity.;mdtC
mdtD.3001330.U00096.2161463_2162879.299	mdtD.3001330.U00096.2161463_2162879.299	1	0	539	652	mdtD	1416	1416	98.38	mdtD.l15.c30.ctg.1	2077	23.7	0	.	p	.	0	D3E	NONSYN	7	9	GAT	268	270	GAA	17;17;16	G;A;A	17;17;16	.	Efflux pump mdtD;mdtD
mdtD.3001330.U00096.2161463_2162879.299	mdtD.3001330.U00096.2161463_2162879.299	1	0	539	652	mdtD	1416	1416	98.38	mdtD.l15.c30.ctg.1	2077	23.7	0	.	p	.	0	T226A	NONSYN	676	678	ACG	937	939	GCG	39;39;39	G;C;G	39;39;39	.	Efflux pump mdtD;mdtD
mdtD.3001330.U00096.2161463_2162879.299	mdtD.3001330.U00096.2161463_2162879.299	1	0	539	652	mdtD	1416	1416	98.38	mdtD.l15.c30.ctg.1	2077	23.7	0	.	p	.	0	V340I	NONSYN	1018	1020	GTC	1279	1281	ATC	40;40;40	A;T;C	40;40;40	.	Efflux pump mdtD;mdtD
mdtD.3001330.U00096.2161463_2162879.299	mdtD.3001330.U00096.2161463_2162879.299	1	0	539	652	mdtD	1416	1416	98.38	mdtD.l15.c30.ctg.1	2077	23.7	0	.	p	.	0	L441F	NONSYN	1321	1323	TTG	1582	1584	TTT	33;35;35	T;T;T	33;35;35	.	Efflux pump mdtD;mdtD
mdtE.3000795.AP009048.3980025_3981183.753	mdtE.3000795.AP009048.3980025_3981183.753	1	0	27	474	mdtE	1158	1158	99.31	mdtE.l15.c4.ctg.1	1706	20.9	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	MdtE is the membrane fusion protein of the MdtEF multidrug efflux complex. It shares 70% sequence similarity with AcrA.;mdtE
mdtF.3000796.U00096.3660413_3663527.286	mdtF.3000796.U00096.3660413_3663527.286	1	0	539	1370	mdtF	3114	3114	98.52	mdtF.l15.c30.ctg.1	3601	28.7	0	.	p	.	0	A295T	NONSYN	883	885	GCC	1108	1110	ACC	23;24;22	A;C;C	23;24;22	.	mdtF;MdtF is the multidrug inner membrane transporter for the MdtEF-TolC efflux complex.
mdtF.3000796.U00096.3660413_3663527.286	mdtF.3000796.U00096.3660413_3663527.286	1	0	539	1370	mdtF	3114	3114	98.52	mdtF.l15.c30.ctg.1	3601	28.7	0	.	p	.	0	N709D	NONSYN	2125	2127	AAT	2350	2352	GAC	33;33;33	G;A;C	33;32;33	.	mdtF;MdtF is the multidrug inner membrane transporter for the MdtEF-TolC efflux complex.
mdtG.3001329.NC_007779.1115840_1117067.599	mdtG.3001329.NC_007779.1115840_1117067.599	1	0	513	412	mdtG	1227	1047	99.43	mdtG.l15.c4.ctg.1	1497	18.0	0	.	p	.	0	V200I	NONSYN	598	600	GTC	543	545	ATC	24;25;27	A;T;C	23;24;25	.	mdtG;Efflux protien mdtG.
mdtG.3001329.NC_007779.1115840_1117067.599	mdtG.3001329.NC_007779.1115840_1117067.599	1	0	513	412	mdtG	1227	182	99.45	mdtG.l15.c4.ctg.2	490	7.4	0	.	p	.	0	E5G	NONSYN	13	15	GAA	212	214	GGA	7;7;7	G;G;A	7;7;7	.	mdtG;Efflux protien mdtG.
mdtH.3001216.U00096.1124117_1125326.120	mdtH.3001216.U00096.1124117_1125326.120	1	0	539	472	mdtH	1209	1209	98.18	mdtH.l15.c30.ctg.1	1615	22.0	0	.	p	.	0	G134C	NONSYN	400	402	GGT	616	618	TGT	25;26;26	T;G;T	25;26;26	.	mdtH;Multidrug resistance protein MdtH
mdtH.3001216.U00096.1124117_1125326.120	mdtH.3001216.U00096.1124117_1125326.120	1	0	539	472	mdtH	1209	1209	98.18	mdtH.l15.c30.ctg.1	1615	22.0	0	.	p	.	0	S324L	NONSYN	970	972	TCG	1186	1188	TTG	26;25;25	T;T;G	25;25;24	.	mdtH;Multidrug resistance protein MdtH
mdtH.3001216.U00096.1124117_1125326.120	mdtH.3001216.U00096.1124117_1125326.120	1	0	539	472	mdtH	1209	1209	98.18	mdtH.l15.c30.ctg.1	1615	22.0	0	.	p	.	0	A394T	NONSYN	1180	1182	GCG	1396	1398	ACG	4;4;3	A;C;G	4;4;3	.	mdtH;Multidrug resistance protein MdtH
mdtL.3001215.U00096.3891614_3892790.621	mdtL.3001215.U00096.3891614_3892790.621	1	0	539	504	mdtL	1176	1176	98.38	mdtL.l15.c30.ctg.1	1744	21.6	0	.	p	.	0	A185S	NONSYN	553	555	GCC	790	792	TCC	13;13;13	T;C;C	13;13;13	.	Multidrug resistance protein MdtL;mdtL
mdtN.3003548.AP009048.4306556_4307588.3298	mdtN.3003548.AP009048.4306556_4307588.3298	1	0	539	370	mdtN	1032	1032	98.06	mdtN.l15.c30.ctg.1	1451	19.1	0	.	p	.	0	V119I	NONSYN	355	357	GTT	541	543	ATT	36;36;37	A;T;T	36;36;37	.	mdtN;Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride.
mdtO.3003549.AP009048.4304505_4306557.3300	mdtO.3003549.AP009048.4304505_4306557.3300	1	0	539	854	mdtO	2052	2052	98.1	mdtO.l15.c30.ctg.1	2430	26.1	0	.	p	.	0	V11M	NONSYN	31	33	GTG	72	74	ATG	11;11;11	A;T;G	11;11;11	.	mdtO;Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride
mdtO.3003549.AP009048.4304505_4306557.3300	mdtO.3003549.AP009048.4304505_4306557.3300	1	0	539	854	mdtO	2052	2052	98.1	mdtO.l15.c30.ctg.1	2430	26.1	0	.	p	.	0	T33I	NONSYN	97	99	ACC	138	140	ATC	16;16;16	A;T;C	15;14;16	.	mdtO;Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride
mdtO.3003549.AP009048.4304505_4306557.3300	mdtO.3003549.AP009048.4304505_4306557.3300	1	0	539	854	mdtO	2052	2052	98.1	mdtO.l15.c30.ctg.1	2430	26.1	0	.	p	.	0	C116R	NONSYN	346	348	TGC	387	389	CGC	24;25;25	C;G;C	24;25;25	.	mdtO;Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride
mdtO.3003549.AP009048.4304505_4306557.3300	mdtO.3003549.AP009048.4304505_4306557.3300	1	0	539	854	mdtO	2052	2052	98.1	mdtO.l15.c30.ctg.1	2430	26.1	0	.	p	.	0	N238S	NONSYN	712	714	AAC	753	755	AGC	26;26;25	A;G;C	26;26;24	.	mdtO;Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride
mdtO.3003549.AP009048.4304505_4306557.3300	mdtO.3003549.AP009048.4304505_4306557.3300	1	0	539	854	mdtO	2052	2052	98.1	mdtO.l15.c30.ctg.1	2430	26.1	0	.	p	.	0	M305V	NONSYN	913	915	ATG	954	956	GTG	26;26;25	G;T;G	26;25;25	.	mdtO;Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride
mdtO.3003549.AP009048.4304505_4306557.3300	mdtO.3003549.AP009048.4304505_4306557.3300	1	0	539	854	mdtO	2052	2052	98.1	mdtO.l15.c30.ctg.1	2430	26.1	0	.	p	.	0	D326N	NONSYN	976	978	GAC	1017	1019	AAC	23;23;24	A;A,C;C	18;16,1;21	.	mdtO;Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride
mdtO.3003549.AP009048.4304505_4306557.3300	mdtO.3003549.AP009048.4304505_4306557.3300	1	0	539	854	mdtO	2052	2052	98.1	mdtO.l15.c30.ctg.1	2430	26.1	0	.	p	.	0	A341V	NONSYN	1021	1023	GCC	1062	1064	GTC	23;23;22	G;T;C	22;21;22	.	mdtO;Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride
mdtO.3003549.AP009048.4304505_4306557.3300	mdtO.3003549.AP009048.4304505_4306557.3300	1	0	539	854	mdtO	2052	2052	98.1	mdtO.l15.c30.ctg.1	2430	26.1	0	.	p	.	0	M351I	NONSYN	1051	1053	ATG	1092	1094	ATA	23;24;23	A;T;A	23;23;23	.	mdtO;Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride
mdtO.3003549.AP009048.4304505_4306557.3300	mdtO.3003549.AP009048.4304505_4306557.3300	1	0	539	854	mdtO	2052	2052	98.1	mdtO.l15.c30.ctg.1	2430	26.1	0	.	p	.	0	A387S	NONSYN	1159	1161	GCT	1200	1202	TCT	26;28;28	T;C;T	26;28;28	.	mdtO;Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride
mdtO.3003549.AP009048.4304505_4306557.3300	mdtO.3003549.AP009048.4304505_4306557.3300	1	0	539	854	mdtO	2052	2052	98.1	mdtO.l15.c30.ctg.1	2430	26.1	0	.	p	.	0	T516A	NONSYN	1546	1548	ACG	1587	1589	GCG	35;34;34	G;C;G	35;34;34	.	mdtO;Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride
mdtO.3003549.AP009048.4304505_4306557.3300	mdtO.3003549.AP009048.4304505_4306557.3300	1	0	539	854	mdtO	2052	2052	98.1	mdtO.l15.c30.ctg.1	2430	26.1	0	.	p	.	0	L587I	NONSYN	1759	1761	CTT	1800	1802	ATC	32;32;29	A;T;C	32;31;29	.	mdtO;Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride
mdtP.3003550.AP009048.4303042_4304509.3303	mdtP.3003550.AP009048.4303042_4304509.3303	1	0	539	534	mdtP	1467	1467	97.96	mdtP.l15.c4.ctg.1	1828	21.9	0	.	p	.	0	S129A	NONSYN	385	387	TCA	591	593	GCG	35;34;34	G;C;G	35;34;34	.	Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride;mdtP
mdtP.3003550.AP009048.4303042_4304509.3303	mdtP.3003550.AP009048.4303042_4304509.3303	1	0	539	534	mdtP	1467	1467	97.96	mdtP.l15.c4.ctg.1	1828	21.9	0	.	p	.	0	A187T	NONSYN	559	561	GCC	765	767	ACC	36;37;37	A;C;C	36;36;37	.	Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride;mdtP
mdtP.3003550.AP009048.4303042_4304509.3303	mdtP.3003550.AP009048.4303042_4304509.3303	1	0	539	534	mdtP	1467	1467	97.96	mdtP.l15.c4.ctg.1	1828	21.9	0	.	p	.	0	H211R	NONSYN	631	633	CAC	837	839	CGC	32;32;32	C;G;C	32;32;32	.	Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride;mdtP
mdtP.3003550.AP009048.4303042_4304509.3303	mdtP.3003550.AP009048.4303042_4304509.3303	1	0	539	534	mdtP	1467	1467	97.96	mdtP.l15.c4.ctg.1	1828	21.9	0	.	p	.	0	V250A	NONSYN	748	750	GTT	954	956	GCT	18;18;18	G;C;T	18;18;18	.	Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride;mdtP
mdtP.3003550.AP009048.4303042_4304509.3303	mdtP.3003550.AP009048.4303042_4304509.3303	1	0	539	534	mdtP	1467	1467	97.96	mdtP.l15.c4.ctg.1	1828	21.9	0	.	p	.	0	R278K	NONSYN	832	834	AGA	1038	1040	AAA	19;19;19	A;A;A	19;19;19	.	Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride;mdtP
mdtP.3003550.AP009048.4303042_4304509.3303	mdtP.3003550.AP009048.4303042_4304509.3303	1	0	539	534	mdtP	1467	1467	97.96	mdtP.l15.c4.ctg.1	1828	21.9	0	.	p	.	0	Q284R	NONSYN	850	852	CAA	1056	1058	CGA	19;19;19	C;G;A	19;19;18	.	Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride;mdtP
mdtP.3003550.AP009048.4303042_4304509.3303	mdtP.3003550.AP009048.4303042_4304509.3303	1	0	539	534	mdtP	1467	1467	97.96	mdtP.l15.c4.ctg.1	1828	21.9	0	.	p	.	0	S339A	NONSYN	1015	1017	TCC	1221	1223	GCC	16;15;16	G;C;C	16;15;16	.	Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride;mdtP
mdtP.3003550.AP009048.4303042_4304509.3303	mdtP.3003550.AP009048.4303042_4304509.3303	1	0	539	534	mdtP	1467	1467	97.96	mdtP.l15.c4.ctg.1	1828	21.9	0	.	p	.	0	H343D	NONSYN	1027	1029	CAT	1233	1235	GAT	16;17;18	G;A;T	16;17;18	.	Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride;mdtP
mdtP.3003550.AP009048.4303042_4304509.3303	mdtP.3003550.AP009048.4303042_4304509.3303	1	0	539	534	mdtP	1467	1467	97.96	mdtP.l15.c4.ctg.1	1828	21.9	0	.	p	.	0	G482A	NONSYN	1444	1446	GGT	1650	1652	GCT	7;7;7	G;C;T	7;7;6	.	Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride;mdtP
mfd.3003844.NC_000913.3.1170517_1173964.3609	mfd.3003844.NC_000913.3.1170517_1173964.3609	1	0	539	1402	mfd	3447	3447	99.16	mfd.l15.c30.ctg.1	4107	25.7	0	.	p	.	0	T437K	NONSYN	1309	1311	ACG	1626	1628	AAG	24;25;24	A;A;G	23;25;23	.	mfd dissociates transcription elongation complexes blocked at nonpairing lesions and mediates recruitment of DNA repair proteins. The Mfd (mutation frequency decline) protein, also known as transcription-repair coupling factor, is responsible for ATP-dependent removal of stalled RNA polymerase from DNA lesions by inducing forward movement of the RNA polymerase and subsequent recruitment of nucleotide excision repair machinery to the sites of the lesions.;mfd
mfd.3003844.NC_000913.3.1170517_1173964.3609	mfd.3003844.NC_000913.3.1170517_1173964.3609	1	0	539	1402	mfd	3447	3447	99.16	mfd.l15.c30.ctg.1	4107	25.7	0	.	p	.	0	M796L	NONSYN	2386	2388	ATG	2703	2705	CTG	24;26;24	C;T;G	23;25;24	.	mfd dissociates transcription elongation complexes blocked at nonpairing lesions and mediates recruitment of DNA repair proteins. The Mfd (mutation frequency decline) protein, also known as transcription-repair coupling factor, is responsible for ATP-dependent removal of stalled RNA polymerase from DNA lesions by inducing forward movement of the RNA polymerase and subsequent recruitment of nucleotide excision repair machinery to the sites of the lesions.;mfd
mgrB.3003820.NC_000913.3.1908622_1908766.3586	mgrB.3003820.NC_000913.3.1908622_1908766.3586	1	0	27	120	mgrB	144	144	100.0	mgrB.l15.c30.ctg.1	612	14.3	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	mgrB;mgrB is a small transmembrane protein produced in the PhoPQ signalling system. It acts as a negative regulator in this system. Inactivation or down-regulation of mgrB confers colistin resistance by absence as shown in Klebsiella pneumoniae
msbA.3003950.NC_000913.3.966620_968369.3754	msbA.3003950.NC_000913.3.966620_968369.3754	1	0	539	724	msbA	1749	1749	98.68	msbA.l15.c17.ctg.1	2303	23.7	0	.	p	.	0	S278N	NONSYN	832	834	AGC	1046	1048	AAC	21;22;21	A;A;C	21;22;21	.	msbA;MsbA is a multidrug resistance transporter homolog from E. coli and belongs to a superfamily of transporters that contain an adenosine triphosphate (ATP) binding cassette (ABC) which is also called a nucleotide-binding domain (NBD). MsbA is a member of the MDR-ABC transporter group by sequence homology. MsbA transports lipid A, a major component of the bacterial outer cell membrane, and is the only bacterial ABC transporter that is essential for cell viability.
msbA.3003950.NC_000913.3.966620_968369.3754	msbA.3003950.NC_000913.3.966620_968369.3754	1	0	539	724	msbA	1749	1749	98.68	msbA.l15.c17.ctg.1	2303	23.7	0	.	p	.	0	M460I	NONSYN	1378	1380	ATG	1592	1594	ATA	26;26;25	A;T;A	26;26;25	.	msbA;MsbA is a multidrug resistance transporter homolog from E. coli and belongs to a superfamily of transporters that contain an adenosine triphosphate (ATP) binding cassette (ABC) which is also called a nucleotide-binding domain (NBD). MsbA is a member of the MDR-ABC transporter group by sequence homology. MsbA transports lipid A, a major component of the bacterial outer cell membrane, and is the only bacterial ABC transporter that is essential for cell viability.
murA.3003775.CP009072.1414817_1416077.3548	murA.3003775.CP009072.1414817_1416077.3548	1	1	27	592	murA_12	1260	1260	98.49	murA_12.l6.c30.ctg.1	1973	22.6	1	SNP	p	D369N	0	.	.	1105	1107	GAT	1381	1383	GAT	29;29;29	G;A;T	29;29;29	murA.3003775.CP009072.1414817_1416077.3548:1:1:D369N:.:murA or UDP-N-acetylglucosamine enolpyruvyl transferase catalyses the initial step in peptidoglycan biosynthesis and is inhibited by fosfomycin. Overexpression of murA through mutations such as Asp369Asn and Leu370Ile confers fosfomycin resistance. Extensive evidence has shown the significance of C115 mutations in conferring fosfomycin resistance since this residue represents a primary binding site for the antibiotic across many species.	Escherichia coli mutant murA conferring resistance to fosfomycin
murA.3003775.CP009072.1414817_1416077.3548	murA.3003775.CP009072.1414817_1416077.3548	1	1	27	592	murA_12	1260	1260	98.49	murA_12.l6.c30.ctg.1	1973	22.6	1	SNP	p	L370I	0	.	.	1108	1110	CTG	1384	1386	CTG	29;29;28	C;T;G	29;29;28	murA.3003775.CP009072.1414817_1416077.3548:1:1:L370I:.:murA or UDP-N-acetylglucosamine enolpyruvyl transferase catalyses the initial step in peptidoglycan biosynthesis and is inhibited by fosfomycin. Overexpression of murA through mutations such as Asp369Asn and Leu370Ile confers fosfomycin resistance. Extensive evidence has shown the significance of C115 mutations in conferring fosfomycin resistance since this residue represents a primary binding site for the antibiotic across many species.	Escherichia coli mutant murA conferring resistance to fosfomycin
nfsA.3003751.NC_000913.3.891183_891906.3520	nfsA.3003751.NC_000913.3.891183_891906.3520	1	1	539	248	nfsA	723	723	99.03	nfsA.l15.c30.ctg.1	1153	16.0	0	.	p	.	0	R27C	NONSYN	79	81	CGT	297	299	TGT	26;26;28	T;G;T	26;26;28	.	Escherichia coli nfsA mutations conferring resistance to nitrofurantoin
nfsA.3003751.NC_000913.3.891183_891906.3520	nfsA.3003751.NC_000913.3.891183_891906.3520	1	1	539	248	nfsA	723	723	99.03	nfsA.l15.c30.ctg.1	1153	16.0	0	.	p	.	0	I117T	NONSYN	349	351	ATC	567	569	ACC	31;31;30	A;C;C	31;30;30	.	Escherichia coli nfsA mutations conferring resistance to nitrofurantoin
nfsA.3003751.NC_000913.3.891183_891906.3520	nfsA.3003751.NC_000913.3.891183_891906.3520	1	1	539	248	nfsA	723	723	99.03	nfsA.l15.c30.ctg.1	1153	16.0	0	.	p	.	0	G187D	NONSYN	559	561	GGC	777	779	GAC	18;18;18	G;A;C	18;18;18	.	Escherichia coli nfsA mutations conferring resistance to nitrofurantoin
nfsA.3003751.NC_000913.3.891183_891906.3520	nfsA.3003751.NC_000913.3.891183_891906.3520	1	1	539	248	nfsA	723	723	99.03	nfsA.l15.c30.ctg.1	1153	16.0	1	SNP	p	R15C	0	.	.	43	45	CGC	261	263	CGC	25;24;24	C;G;C	25;24;24	nfsA.3003751.NC_000913.3.891183_891906.3520:1:1:R15C:.:nfsA encodes the major oxygen-insesitive nitroreductase in E. coli. The first step of resistance to nitrofurazone is mutation of nfsA.	Escherichia coli nfsA mutations conferring resistance to nitrofurantoin
nfsA.3003751.NC_000913.3.891183_891906.3520	nfsA.3003751.NC_000913.3.891183_891906.3520	1	1	539	248	nfsA	723	723	99.03	nfsA.l15.c30.ctg.1	1153	16.0	1	SNP	p	S33R	0	.	.	97	99	AGC	315	317	AGC	28;28;29	A;G;C	28;28;29	nfsA.3003751.NC_000913.3.891183_891906.3520:1:1:S33R:.:nfsA encodes the major oxygen-insesitive nitroreductase in E. coli. The first step of resistance to nitrofurazone is mutation of nfsA.	Escherichia coli nfsA mutations conferring resistance to nitrofurantoin
nfsA.3003751.NC_000913.3.891183_891906.3520	nfsA.3003751.NC_000913.3.891183_891906.3520	1	1	539	248	nfsA	723	723	99.03	nfsA.l15.c30.ctg.1	1153	16.0	1	SNP	p	G131D	0	.	.	391	393	GGC	609	611	GGC	26;26;26	G;G;C	26;26;26	nfsA.3003751.NC_000913.3.891183_891906.3520:1:1:G131D:.:nfsA encodes the major oxygen-insesitive nitroreductase in E. coli. The first step of resistance to nitrofurazone is mutation of nfsA.	Escherichia coli nfsA mutations conferring resistance to nitrofurantoin
nfsA.3003751.NC_000913.3.891183_891906.3520	nfsA.3003751.NC_000913.3.891183_891906.3520	1	1	539	248	nfsA	723	723	99.03	nfsA.l15.c30.ctg.1	1153	16.0	1	SNP	p	R203C	0	.	.	607	609	CGT	825	827	CGT	24;24;23	C;G;T	24;24;22	nfsA.3003751.NC_000913.3.891183_891906.3520:1:1:R203C:.:nfsA encodes the major oxygen-insesitive nitroreductase in E. coli. The first step of resistance to nitrofurazone is mutation of nfsA.	Escherichia coli nfsA mutations conferring resistance to nitrofurantoin
nfsA.3003751.NC_000913.3.891183_891906.3520	nfsA.3003751.NC_000913.3.891183_891906.3520	1	1	539	248	nfsA	723	723	99.03	nfsA.l15.c30.ctg.1	1153	16.0	1	SNP	p	R203L	0	.	.	607	609	CGT	825	827	CGT	24;24;23	C;G;T	24;24;22	nfsA.3003751.NC_000913.3.891183_891906.3520:1:1:R203L:.:nfsA encodes the major oxygen-insesitive nitroreductase in E. coli. The first step of resistance to nitrofurazone is mutation of nfsA.	Escherichia coli nfsA mutations conferring resistance to nitrofurantoin
ompF.3003390.NC_007779.986315_987404.2075	ompF.3003390.NC_007779.986315_987404.2075	1	1	539	554	ompF	1089	1089	99.91	ompF.l15.c4.ctg.1	1581	26.2	0	.	p	.	0	D312E	NONSYN	934	936	GAT	1172	1174	GAG	31;31;32	G;A;G	31;31;32	.	Escherichia coli ompF mutants
ompF.3003390.NC_007779.986315_987404.2075	ompF.3003390.NC_007779.986315_987404.2075	1	1	539	554	ompF	1089	1089	99.91	ompF.l15.c4.ctg.1	1581	26.2	1	SNP	p	G141D	0	.	.	421	423	GGT	659	661	GGT	39;40;40	G;G;T	38;39;39	ompF.3003390.NC_007779.986315_987404.2075:1:1:G141D:.:Mutant forms of the Escherichia coli outer membrane porin OmpF result in reduced permeability to antibiotics.	Escherichia coli ompF mutants
ompF.3003390.NC_007779.986315_987404.2075	ompF.3003390.NC_007779.986315_987404.2075	1	1	539	554	ompF	1089	1089	99.91	ompF.l15.c4.ctg.1	1581	26.2	1	SNP	p	G141E	0	.	.	421	423	GGT	659	661	GGT	39;40;40	G;G;T	38;39;39	ompF.3003390.NC_007779.986315_987404.2075:1:1:G141E:.:Mutant forms of the Escherichia coli outer membrane porin OmpF result in reduced permeability to antibiotics.	Escherichia coli ompF mutants
ompF.3003390.NC_007779.986315_987404.2075	ompF.3003390.NC_007779.986315_987404.2075	1	1	539	554	ompF	1089	1089	99.91	ompF.l15.c4.ctg.1	1581	26.2	1	SNP	p	R154D	0	.	.	460	462	CGT	698	700	CGT	44;46;46	C;G;T	44;46;46	ompF.3003390.NC_007779.986315_987404.2075:1:1:R154D:.:Mutant forms of the Escherichia coli outer membrane porin OmpF result in reduced permeability to antibiotics.	Escherichia coli ompF mutants
ompF.3003390.NC_007779.986315_987404.2075	ompF.3003390.NC_007779.986315_987404.2075	1	1	539	554	ompF	1089	1089	99.91	ompF.l15.c4.ctg.1	1581	26.2	1	SNP	p	R154A	0	.	.	460	462	CGT	698	700	CGT	44;46;46	C;G;T	44;46;46	ompF.3003390.NC_007779.986315_987404.2075:1:1:R154A:.:Mutant forms of the Escherichia coli outer membrane porin OmpF result in reduced permeability to antibiotics.	Escherichia coli ompF mutants
parC.3003941.NC_004337.2.3159154_3161413.3742	parC.3003941.NC_004337.2.3159154_3161413.3742	1	1	539	1088	parC_2	2259	2259	99.25	parC_2.l15.c30.ctg.1	2820	29.0	0	.	p	.	0	A533V	NONSYN	1597	1599	GCG	1873	1875	GTG	23;23;22	G;T;G	23;23;22	.	Shigella flexneri parC conferring resistance to fluoroquinolones
parC.3003941.NC_004337.2.3159154_3161413.3742	parC.3003941.NC_004337.2.3159154_3161413.3742	1	1	539	1088	parC_2	2259	2259	99.25	parC_2.l15.c30.ctg.1	2820	29.0	0	.	p	.	0	P542S	NONSYN	1624	1626	CCG	1900	1902	TCG	30;30;31	T;C;G	27;28;31	.	Shigella flexneri parC conferring resistance to fluoroquinolones
parC.3003941.NC_004337.2.3159154_3161413.3742	parC.3003941.NC_004337.2.3159154_3161413.3742	1	1	539	1088	parC_2	2259	2259	99.25	parC_2.l15.c30.ctg.1	2820	29.0	0	.	p	.	0	S747N	NONSYN	2239	2241	AGC	2515	2517	AAC	28;28;27	A;A;C	27;28;27	.	Shigella flexneri parC conferring resistance to fluoroquinolones
parC.3003941.NC_004337.2.3159154_3161413.3742	parC.3003941.NC_004337.2.3159154_3161413.3742	1	1	539	1088	parC_2	2259	2259	99.25	parC_2.l15.c30.ctg.1	2820	29.0	1	SNP	p	A85T	0	.	.	253	255	GCG	529	531	GCG	40;39;39	G;C;G	39;38;39	parC.3003941.NC_004337.2.3159154_3161413.3742:1:1:A85T:.:Point mutation in parC conferring resistance to fluoroquinolone antibiotics in Shigella flexneri,	Shigella flexneri parC conferring resistance to fluoroquinolones
parC.3003941.NC_004337.2.3159154_3161413.3742	parC.3003941.NC_004337.2.3159154_3161413.3742	1	1	539	1088	parC_2	2259	2259	99.25	parC_2.l15.c30.ctg.1	2820	29.0	1	SNP	p	D111H	0	.	.	331	333	GAT	607	609	GAT	33;33;33	G;A;T	32;33;33	parC.3003941.NC_004337.2.3159154_3161413.3742:1:1:D111H:.:Point mutation in parC conferring resistance to fluoroquinolone antibiotics in Shigella flexneri,	Shigella flexneri parC conferring resistance to fluoroquinolones
parC.3003941.NC_004337.2.3159154_3161413.3742	parC.3003941.NC_004337.2.3159154_3161413.3742	1	1	539	1088	parC_2	2259	2259	99.25	parC_2.l15.c30.ctg.1	2820	29.0	1	SNP	p	S129P	0	.	.	385	387	TCC	661	663	TCC	30;30;28	T;C;C	29;29;28	parC.3003941.NC_004337.2.3159154_3161413.3742:1:1:S129P:.:Point mutation in parC conferring resistance to fluoroquinolone antibiotics in Shigella flexneri,	Shigella flexneri parC conferring resistance to fluoroquinolones
parE.3003316.NC_007779.3172159_3174052.2073	parE.3003316.NC_007779.3172159_3174052.2073	1	1	539	734	parE_1	1893	1893	97.52	parE_1.l15.c30.ctg.1	2498	22.0	0	.	p	.	0	D473N	NONSYN	1417	1419	GAC	1728	1730	AAC	36;36;37	A;A;C	36;36;37	.	Escherichia coli parE conferring resistance to fluoroquinolones
parE.3003316.NC_007779.3172159_3174052.2073	parE.3003316.NC_007779.3172159_3174052.2073	1	1	539	734	parE_1	1893	1893	97.52	parE_1.l15.c30.ctg.1	2498	22.0	1	SNP	p	D476N	0	.	.	1426	1428	GAT	1737	1739	GAT	33;36;36	G;A;T	33;36;36	parE.3003316.NC_007779.3172159_3174052.2073:1:1:D476N:.:Point mutation in Escherichia coli parE resulting in fluoroquinolones resistance	Escherichia coli parE conferring resistance to fluoroquinolones
patA.3000024.NC_000913.3.3219493_3220873.3692	patA.3000024.NC_000913.3.3219493_3220873.3692	1	0	539	638	patA	1380	1380	99.78	patA.l15.c30.ctg.1	1937	24.3	0	.	p	.	0	P202Q	NONSYN	604	606	CCG	864	866	CAG	31;31;31	C;A;G	31;31;31	.	PatA is an ABC transporter of Streptococcus pneumoniae that interacts with PatB to confer fluoroquinolone resistance.;patA
patA.3000024.NC_000913.3.3219493_3220873.3692	patA.3000024.NC_000913.3.3219493_3220873.3692	1	0	539	638	patA	1380	1380	99.78	patA.l15.c30.ctg.1	1937	24.3	0	.	p	.	0	E360D	NONSYN	1078	1080	GAG	1338	1340	GAT	23;23;23	G;A;T	23;23;23	.	PatA is an ABC transporter of Streptococcus pneumoniae that interacts with PatB to confer fluoroquinolone resistance.;patA
rpoB.3003288.NC_002695.4990140_4994169.2096	rpoB.3003288.NC_002695.4990140_4994169.2096	1	1	27	1900	rpoB	4029	4029	99.03	rpoB.l15.c30.ctg.1	4581	31.3	1	SNP	p	V146F	0	.	.	436	438	GTT	732	734	GTT	28;27;28	G;T;T	28;27;28	rpoB.3003288.NC_002695.4990140_4994169.2096:1:1:V146F:.:Point mutations that occurs in Escherichia coli rpoB resulting in resistance to rifampicin	Escherichia coli rpoB mutants conferring resistance to rifampicin
rpoB.3003288.NC_002695.4990140_4994169.2096	rpoB.3003288.NC_002695.4990140_4994169.2096	1	1	27	1900	rpoB	4029	4029	99.03	rpoB.l15.c30.ctg.1	4581	31.3	1	SNP	p	Q513P	0	.	.	1537	1539	CAG	1833	1835	CAG	37;37;37	C;A;G	37;37;37	rpoB.3003288.NC_002695.4990140_4994169.2096:1:1:Q513P:.:Point mutations that occurs in Escherichia coli rpoB resulting in resistance to rifampicin	Escherichia coli rpoB mutants conferring resistance to rifampicin
rpoB.3003288.NC_002695.4990140_4994169.2096	rpoB.3003288.NC_002695.4990140_4994169.2096	1	1	27	1900	rpoB	4029	4029	99.03	rpoB.l15.c30.ctg.1	4581	31.3	1	SNP	p	Q513L	0	.	.	1537	1539	CAG	1833	1835	CAG	37;37;37	C;A;G	37;37;37	rpoB.3003288.NC_002695.4990140_4994169.2096:1:1:Q513L:.:Point mutations that occurs in Escherichia coli rpoB resulting in resistance to rifampicin	Escherichia coli rpoB mutants conferring resistance to rifampicin
rpoB.3003288.NC_002695.4990140_4994169.2096	rpoB.3003288.NC_002695.4990140_4994169.2096	1	1	27	1900	rpoB	4029	4029	99.03	rpoB.l15.c30.ctg.1	4581	31.3	1	SNP	p	H526Y	0	.	.	1576	1578	CAC	1872	1874	CAC	39;37;37	C;A;C	39;36;37	rpoB.3003288.NC_002695.4990140_4994169.2096:1:1:H526Y:.:Point mutations that occurs in Escherichia coli rpoB resulting in resistance to rifampicin	Escherichia coli rpoB mutants conferring resistance to rifampicin
rpoB.3003288.NC_002695.4990140_4994169.2096	rpoB.3003288.NC_002695.4990140_4994169.2096	1	1	27	1900	rpoB	4029	4029	99.03	rpoB.l15.c30.ctg.1	4581	31.3	1	SNP	p	R529C	0	.	.	1585	1587	CGT	1881	1883	CGT	34;32;32	C;G;T	34;32;32	rpoB.3003288.NC_002695.4990140_4994169.2096:1:1:R529C:.:Point mutations that occurs in Escherichia coli rpoB resulting in resistance to rifampicin	Escherichia coli rpoB mutants conferring resistance to rifampicin
rpoB.3003288.NC_002695.4990140_4994169.2096	rpoB.3003288.NC_002695.4990140_4994169.2096	1	1	27	1900	rpoB	4029	4029	99.03	rpoB.l15.c30.ctg.1	4581	31.3	1	SNP	p	R529S	0	.	.	1585	1587	CGT	1881	1883	CGT	34;32;32	C;G;T	34;32;32	rpoB.3003288.NC_002695.4990140_4994169.2096:1:1:R529S:.:Point mutations that occurs in Escherichia coli rpoB resulting in resistance to rifampicin	Escherichia coli rpoB mutants conferring resistance to rifampicin
rpoB.3003288.NC_002695.4990140_4994169.2096	rpoB.3003288.NC_002695.4990140_4994169.2096	1	1	27	1900	rpoB	4029	4029	99.03	rpoB.l15.c30.ctg.1	4581	31.3	1	SNP	p	S531F	0	.	.	1591	1593	TCC	1887	1889	TCC	32;32;32	T;C;C	32;32;32	rpoB.3003288.NC_002695.4990140_4994169.2096:1:1:S531F:.:Point mutations that occurs in Escherichia coli rpoB resulting in resistance to rifampicin	Escherichia coli rpoB mutants conferring resistance to rifampicin
rpoB.3003288.NC_002695.4990140_4994169.2096	rpoB.3003288.NC_002695.4990140_4994169.2096	1	1	27	1900	rpoB	4029	4029	99.03	rpoB.l15.c30.ctg.1	4581	31.3	1	SNP	p	L533P	0	.	.	1597	1599	CTC	1893	1895	CTC	30;29;29	C;T;C	30;28;29	rpoB.3003288.NC_002695.4990140_4994169.2096:1:1:L533P:.:Point mutations that occurs in Escherichia coli rpoB resulting in resistance to rifampicin	Escherichia coli rpoB mutants conferring resistance to rifampicin
rpoB.3003288.NC_002695.4990140_4994169.2096	rpoB.3003288.NC_002695.4990140_4994169.2096	1	1	27	1900	rpoB	4029	4029	99.03	rpoB.l15.c30.ctg.1	4581	31.3	1	SNP	p	T563P	0	.	.	1687	1689	ACC	1983	1985	ACC	38;38;40	A;C;C	38;38;40	rpoB.3003288.NC_002695.4990140_4994169.2096:1:1:T563P:.:Point mutations that occurs in Escherichia coli rpoB resulting in resistance to rifampicin	Escherichia coli rpoB mutants conferring resistance to rifampicin
rpoB.3003288.NC_002695.4990140_4994169.2096	rpoB.3003288.NC_002695.4990140_4994169.2096	1	1	27	1900	rpoB	4029	4029	99.03	rpoB.l15.c30.ctg.1	4581	31.3	1	SNP	p	P564L	0	.	.	1690	1692	CCT	1986	1988	CCT	40;40;41	C;C;T	39;40;41	rpoB.3003288.NC_002695.4990140_4994169.2096:1:1:P564L:.:Point mutations that occurs in Escherichia coli rpoB resulting in resistance to rifampicin	Escherichia coli rpoB mutants conferring resistance to rifampicin
rpoB.3003288.NC_002695.4990140_4994169.2096	rpoB.3003288.NC_002695.4990140_4994169.2096	1	1	27	1900	rpoB	4029	4029	99.03	rpoB.l15.c30.ctg.1	4581	31.3	1	SNP	p	R687H	0	.	.	2059	2061	CGT	2355	2357	CGT	59;60;59	C;G;T	59;60;59	rpoB.3003288.NC_002695.4990140_4994169.2096:1:1:R687H:.:Point mutations that occurs in Escherichia coli rpoB resulting in resistance to rifampicin	Escherichia coli rpoB mutants conferring resistance to rifampicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	659	5330	rrsB+	1542	1542	99.94	rrsB+.l15.c30.ctg.1	1950	199.4	0	.	n	.	0	A226G	SNP	226	226	A	342	342	G	219	G	219	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	659	5330	rrsB+	1542	1542	99.94	rrsB+.l15.c30.ctg.1	1950	199.4	1	SNP	n	A794G	0	.	.	794	794	A	910	910	A	212	A	208	rrsC.3003333.U00096.3941808_3943349.3229:0:0:A794G:.:Point mutations in the 3' minor, 3' major, and central domains in the rrsC 16S rRNA gene of Escherichia coli can confer resistance to kasugamicin	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	659	5330	rrsB+	1542	1542	99.94	rrsB+.l15.c30.ctg.1	1950	199.4	1	SNP	n	A794T	0	.	.	794	794	A	910	910	A	212	A	208	rrsC.3003333.U00096.3941808_3943349.3229:0:0:A794T:.:Point mutations in the 3' minor, 3' major, and central domains in the rrsC 16S rRNA gene of Escherichia coli can confer resistance to kasugamicin	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	659	5330	rrsB+	1542	1542	99.94	rrsB+.l15.c30.ctg.1	1950	199.4	1	SNP	n	G926T	0	.	.	926	926	G	1042	1042	G	200	G	199	rrsC.3003333.U00096.3941808_3943349.3229:0:0:G926T:.:Point mutations in the 3' minor, 3' major, and central domains in the rrsC 16S rRNA gene of Escherichia coli can confer resistance to kasugamicin	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	659	5330	rrsB+	1542	1542	99.94	rrsB+.l15.c30.ctg.1	1950	199.4	1	SNP	n	G926C	0	.	.	926	926	G	1042	1042	G	200	G	199	rrsC.3003333.U00096.3941808_3943349.3229:0:0:G926C:.:Point mutations in the 3' minor, 3' major, and central domains in the rrsC 16S rRNA gene of Escherichia coli can confer resistance to kasugamicin	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	659	5330	rrsB+	1542	1542	99.94	rrsB+.l15.c30.ctg.1	1950	199.4	1	SNP	n	G926A	0	.	.	926	926	G	1042	1042	G	200	G	199	rrsC.3003333.U00096.3941808_3943349.3229:0:0:G926A:.:Point mutations in the 3' minor, 3' major, and central domains in the rrsC 16S rRNA gene of Escherichia coli can confer resistance to kasugamicin	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	659	5330	rrsB+	1542	1542	99.94	rrsB+.l15.c30.ctg.1	1950	199.4	1	SNP	n	A1519G	0	.	.	1519	1519	A	1635	1635	A	191	A	190	rrsC.3003333.U00096.3941808_3943349.3229:0:0:A1519G:.:Point mutations in the 3' minor, 3' major, and central domains in the rrsC 16S rRNA gene of Escherichia coli can confer resistance to kasugamicin	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	659	5330	rrsB+	1542	1542	99.94	rrsB+.l15.c30.ctg.1	1950	199.4	1	SNP	n	A1519C	0	.	.	1519	1519	A	1635	1635	A	191	A	190	rrsC.3003333.U00096.3941808_3943349.3229:0:0:A1519C:.:Point mutations in the 3' minor, 3' major, and central domains in the rrsC 16S rRNA gene of Escherichia coli can confer resistance to kasugamicin	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	659	5330	rrsB+	1542	1542	99.94	rrsB+.l15.c30.ctg.1	1950	199.4	1	SNP	n	A1519T	0	.	.	1519	1519	A	1635	1635	A	191	A	190	rrsC.3003333.U00096.3941808_3943349.3229:0:0:A1519T:.:Point mutations in the 3' minor, 3' major, and central domains in the rrsC 16S rRNA gene of Escherichia coli can confer resistance to kasugamicin	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	659	5330	rrsB+	1542	1542	99.94	rrsB+.l15.c30.ctg.1	1950	199.4	0	HET	.	.	.	G1006C	.	1006	1006	G	1122	1122	G	243	G,C	147,91	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	659	5330	rrsB+	1542	1542	99.94	rrsB+.l15.c30.ctg.1	1950	199.4	0	HET	.	.	.	A79G	.	79	79	A	195	195	A	238	A,G	185,52	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	659	5330	rrsB+	1542	1542	99.94	rrsB+.l15.c30.ctg.1	1950	199.4	0	HET	.	.	.	C719T	.	719	719	C	835	835	C	228	C,T	126,101	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	659	5330	rrsB+	1542	1542	99.94	rrsB+.l15.c30.ctg.1	1950	199.4	0	HET	.	.	.	T273A	.	273	273	T	389	389	T	219	T,A	162,56	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	659	5330	rrsB+	1542	1542	99.94	rrsB+.l15.c30.ctg.1	1950	199.4	0	HET	.	.	.	T1010C	.	1010	1010	T	1126	1126	T	234	T,C	136,93	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	659	5330	rrsB+	1542	1542	99.94	rrsB+.l15.c30.ctg.1	1950	199.4	0	HET	.	.	.	C1038T	.	1038	1038	C	1154	1154	C	244	C,T	141,102	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	659	5330	rrsB+	1542	1542	99.94	rrsB+.l15.c30.ctg.1	1950	199.4	0	HET	.	.	.	C183T	.	183	183	C	299	299	C	200	C,T	155,42	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	659	5330	rrsB+	1542	1542	99.94	rrsB+.l15.c30.ctg.1	1950	199.4	0	HET	.	.	.	A250T	.	250	250	A	366	366	A	212	A,T	157,51	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	659	5330	rrsB+	1542	1542	99.94	rrsB+.l15.c30.ctg.1	1950	199.4	0	HET	.	.	.	T90C	.	90	90	T	206	206	T	240	T,C	188,51	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	659	5330	rrsB+	1542	1542	99.94	rrsB+.l15.c30.ctg.1	1950	199.4	0	HET	.	.	.	G474A	.	474	474	G	590	590	G	230	G,A	168,62	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	659	5330	rrsB+	1542	1542	99.94	rrsB+.l15.c30.ctg.1	1950	199.4	0	HET	.	.	.	A253T	.	253	253	A	369	369	A	220	A,T	166,52	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	659	5330	rrsB+	1542	1542	99.94	rrsB+.l15.c30.ctg.1	1950	199.4	0	HET	.	.	.	C194T	.	194	194	C	310	310	C	203	C,T	152,47	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	659	5330	rrsB+	1542	1542	99.94	rrsB+.l15.c30.ctg.1	1950	199.4	0	HET	.	.	.	G1002A	.	1002	1002	G	1118	1118	G	234	G,A	141,92	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
soxR.3003381.U00096.4277468_4277933.2074	soxR.3003381.U00096.4277468_4277933.2074	1	1	27	288	soxR	465	465	100.0	soxR.l15.c30.ctg.1	1077	20.2	1	SNP	p	R20H	0	.	.	58	60	CGC	390	392	CGC	28;28;28	C;G;C	27;28;28	soxR.3003381.U00096.4277468_4277933.2074:1:1:R20H:.:SoxR is a sensory protein that upregulates soxS expression in the presence of redox-cycling drugs. This stress response leads to the expression many multidrug efflux pumps.	Escherichia coli soxR mutants
soxR.3003381.U00096.4277468_4277933.2074	soxR.3003381.U00096.4277468_4277933.2074	1	1	27	288	soxR	465	465	100.0	soxR.l15.c30.ctg.1	1077	20.2	1	SNP	p	G121D	0	.	.	361	363	GGT	693	695	GGT	36;35;33	G;G;T	35;34;33	soxR.3003381.U00096.4277468_4277933.2074:1:1:G121D:.:SoxR is a sensory protein that upregulates soxS expression in the presence of redox-cycling drugs. This stress response leads to the expression many multidrug efflux pumps.	Escherichia coli soxR mutants
soxS.3003511.NC_000913.4277059_4277383.3528	soxS.3003511.NC_000913.4277059_4277383.3528	1	1	539	162	soxS_1	324	324	99.38	soxS_1.l15.c4.ctg.1	875	13.2	0	.	p	.	0	V83I	NONSYN	247	249	GTC	436	438	ATC	19;19;19	A;T;C	19;19;19	.	Escherichia coli soxS mutant
soxS.3003511.NC_000913.4277059_4277383.3528	soxS.3003511.NC_000913.4277059_4277383.3528	1	1	539	162	soxS_1	324	324	99.38	soxS_1.l15.c4.ctg.1	875	13.2	1	SNP	p	A12S	0	.	.	34	36	GCA	223	225	GCA	36;36;35	G;C;A	35;35;35	soxS.3003511.NC_000913.4277059_4277383.3528:1:1:A12S:.:SoxS is a global regulator that up-regulates the expression of AcrAB efflux genes. It also reduces OmpF expression to decrease cell membrane permeability.	Escherichia coli soxS mutant
strA.manually_added_NC_009345_WP_001082319.1_6656_7459	strA.manually_added_NC_009345_WP_001082319.1_6656_7459	1	0	528	12	APH_3____Ib+	804	187	99.47	APH_3____Ib+.l15.c4.ctg.1	187	2.1	0	.	p	.	0	W57L	NONSYN	169	171	TGG	22	24	TTG	2;1;1	T;T,G;G	1;0,1;1	.	Original ref seq: NC_009345.1 Shigella sonnei Ss046 plasmid pSS046_spA, complete sequence
tetR.manually_added_NC_009345_WP_000164043.1_474_1124	tetR.manually_added_NC_009345_WP_000164043.1_474_1124	1	0	16	10	tetR	651	176	100.0	tetR.l15.c4.ctg.1	176	2.2	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Original ref seq: NC_009345.1 Shigella sonnei Ss046 plasmid pSS046_spA, complete sequence
tolC.3000237.FJ768952.0_1488.563	tolC.3000237.FJ768952.0_1488.563	1	0	539	714	tolC	1488	1488	98.66	tolC.l15.c4.ctg.1	2122	25.3	0	.	p	.	0	A294T	NONSYN	880	882	GCT	1184	1186	ACT	30;31;31	A;C;T	29;31;31	.	tolC;TolC is a protein subunit of many multidrug efflux complexes in Gram negative bacteria. It is an outer membrane efflux protein and is constitutively open. Regulation of efflux activity is often at its periplasmic entrance by other components of the efflux complex.
